Transcriptional	O
regulation	O
by	O
C/EBP	B-protein
alpha	I-protein
and	I-protein
-beta	I-protein
in	O
the	O
expression	O
of	O
the	O
gene	O
for	O
the	O
MRP14	B-protein
myeloid	I-protein
calcium	I-protein
binding	I-protein
protein	I-protein
.	O

Transcriptional	O
regulation	O
of	O
the	O
gene	O
for	O
the	O
myeloid	B-protein
calcium	I-protein
binding	I-protein
protein	I-protein
,	O
MRP14	B-protein
,	O
was	O
investigated	O
in	O
human	B-cell_line
monocytic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

The	O
MRP14	B-DNA
gene	I-DNA
was	O
not	O
expressed	O
in	O
monoblastic	B-cell_line
ML-1	I-cell_line
cells	I-cell_line
,	O
promonocytic	B-cell_line
U-937	I-cell_line
cells	I-cell_line
,	O
or	O
promyelocytic	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
gene	O
was	O
expressed	O
in	O
monocytic	B-cell_line
THP-1	I-cell_line
cells	I-cell_line
and	O
in	O
the	O
HL-60	B-cell_line
cells	I-cell_line
treated	O
with	O
1	O
,	O
25-dihydroxyvitamin	O
D3	O
(	O
VD3	O
)	O
.	O

The	O
level	O
of	O
MRP14	B-protein
in	O
VD3-treated	O
HL-60	B-cell_line
cells	I-cell_line
was	O
two-fold	O
higher	O
than	O
that	O
in	O
THP-1	B-cell_line
cells	I-cell_line
.	O

Among	O
several	O
known	O
transcription	B-DNA
factor	I-DNA
binding	I-DNA
motifs	I-DNA
,	O
nuclear	B-protein
protein	I-protein
(	I-protein
s	I-protein
)	I-protein
of	O
VD3-treated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
and	I-cell_line
THP-1	I-cell_line
cells	I-cell_line
bound	O
to	O
the	O
CCAAT/enhancer	B-DNA
binding	I-DNA
protein	I-DNA
(	I-DNA
C/EBP	I-DNA
)	I-DNA
-binding	I-DNA
motif	I-DNA
that	O
was	O
located	O
in	O
the	O
upstream	B-DNA
region	I-DNA
of	O
the	O
MRP14	B-DNA
gene	I-DNA
(	O
-81	O
)	O
,	O
as	O
evidenced	O
by	O
the	O
competitive	O
gel	O
mobility-shift	O
assay	O
.	O

An	O
antibody	O
for	O
C/EBP	B-protein
alpha	I-protein
super-shifted	O
the	O
nucleoprotein	B-protein
complex	I-protein
in	O
THP-1	B-cell_line
cells	I-cell_line
but	O
not	O
in	O
the	O
VD3-treated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
,	O
whereas	O
an	O
antibody	O
for	O
C/EBP	B-protein
beta	I-protein
blocked	O
the	O
formation	O
of	O
the	O
complex	O
with	O
the	O
nuclear	B-protein
factor	I-protein
of	O
the	O
HL-60	B-cell_line
cells	I-cell_line
but	O
not	O
with	O
that	O
of	O
THP-1	B-cell_line
cells	I-cell_line
.	O

An	O
anti-C/EBP	B-protein
delta	I-protein
antibody	I-protein
had	O
no	O
effect	O
on	O
the	O
complex	O
in	O
either	O
cell	O
.	O

Thus	O
,	O
it	O
was	O
concluded	O
that	O
C/EBP	B-protein
alpha	I-protein
and	I-protein
-beta	I-protein
were	O
able	O
to	O
bind	O
to	O
the	O
C/EBP	B-protein
motif	I-protein
,	O
and	O
that	O
C/EBP	B-protein
alpha	I-protein
bound	O
to	O
the	O
motif	O
in	O
THP-1	B-cell_line
cells	I-cell_line
and	O
C/EBP	B-protein
beta	I-protein
bound	O
to	O
that	O
in	O
the	O
VD3-treated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
to	O
examine	O
the	O
transcriptional	O
activity	O
of	O
the	O
C/EBP	B-protein
motif	I-protein
,	O
we	O
transfected	O
several	O
constructed	O
luciferase	B-DNA
reporter	I-DNA
DNAs	I-DNA
into	O
HL-60	B-cell_line
cells	I-cell_line
and	O
THP-1	B-cell_line
cells	I-cell_line
.	O

The	O
luciferase	O
activity	O
of	O
the	O
C/EBP	B-protein
motif	I-protein
in	O
HL-60	B-cell_line
cells	I-cell_line
was	O
increased	O
by	O
VD3	O
treatment	O
.	O

The	O
C/EBP	B-protein
motif	I-protein
in	O
the	O
MRP14	B-DNA
gene	I-DNA
was	O
confirmed	O
to	O
function	O
as	O
a	O
regulatory	O
region	O
in	O
VD3-treated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
and	I-cell_line
THP-1	I-cell_line
cells	I-cell_line
by	O
the	O
assay	O
.	O

Since	O
C/EBP	B-protein
beta	I-protein
was	O
also	O
detected	O
in	O
VD3-untreated	B-cell_line
HL-60	I-cell_line
cells	I-cell_line
by	O
immunoblotting	O
,	O
VD3	O
activated	O
C/EBP	B-protein
beta	I-protein
to	O
bind	O
to	O
the	O
motif	O
,	O
probably	O
through	O
post-translational	O
modification	O
.	O

CELL	NULL
STRUCTURE	NULL
AND	NULL
FUNCTION	NULL
23	NULL
:	NULL
109-118	NULL
(	NULL
1998	NULL
)	NULL
©	NULL
1998	NULL
by	NULL
Japan	NULL
Society	NULL
for	NULL
Cell	NULL
Biology	NULL
Transcriptional	NULL
Regulation	NULL
by	NULL
C/EBPa	NULL
and	NULL
-/	NULL
$	NULL
in	NULL
the	NULL
Expression	NULL
of	NULL
the	NULL
Gene	NULL
for	NULL
the	NULL
MRP14	NULL
Myeloid	NULL
Calcium	NULL
Binding	NULL
Protein	NULL
Ryoko	NULL
Kuruto-Niwa'*	NULL
,	NULL
Michi	NULL
Nakamura	NULL
'	NULL
,	NULL
Keiichi	NULL
Takeishi	NULL
?	NULL

,	NULL
and	NULL
Ryushi	NULL
Nozawa	NULL
!	NULL

Laboratory	NULL
of	NULL
Microbiology	NULL
and	NULL
Host	NULL
Defenses	NULL
and	NULL
Laboratory	NULL
of	NULL
Genetic	NULL
Engineering	NULL
,	NULL
School	NULL
of	NULL
Food	NULL
and	NULL
Nutritional	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Shizuoka	NULL
,	NULL
Yada	NULL
,	NULL
Shizuoka	NULL
422-8526	NULL
,	NULL
Japan	NULL
Key	NULL
words	NULL
:	NULL
-	NULL
C/EBPa/C/EBPB/MRP14/HL-60	NULL
cells/1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
/THP-1	NULL
cells	NULL
ABSTRACT	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
myeloid	NULL
calcium	NULL
binding	NULL
protein	NULL
,	NULL
MRP14	NULL
,	NULL
was	NULL
investigated	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
MRP14	NULL
gene	NULL
was	NULL
not	NULL
expressed	NULL
in	NULL
monoblastic	NULL
ML-1	NULL
cells	NULL
,	NULL
promonocytic	NULL
U-937	NULL
cells	NULL
,	NULL
or	NULL
promyelocytic	NULL
HL-60	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
gene	NULL
was	NULL
expressed	NULL
in	NULL
monocytic	NULL
THP	NULL
cells	NULL
and	NULL
in	NULL
the	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
(	NULL
VD	NULL
;	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
MRP14	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
was	NULL
two-fold	NULL
higher	NULL
than	NULL
that	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Among	NULL
several	NULL
known	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
,	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
of	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
and	NULL
THP-1	NULL
cells	NULL
bound	NULL
to	NULL
the	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
-binding	NULL
motif	NULL
that	NULL
was	NULL
located	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
(	NULL
-81	NULL
)	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
competitive	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
.	NULL

An	NULL
antibody	NULL
for	NULL
C/EBPa	NULL
supershifted	NULL
the	NULL
nucleoprotein	NULL
complex	NULL
in	NULL
THP-1	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
the	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
,	NULL
whereas	NULL
an	NULL
antibody	NULL
for	NULL
C/EBP	NULL
#	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
the	NULL
HL-60	NULL
cells	NULL
but	NULL
not	NULL
with	NULL
that	NULL
of	NULL
THP-1	NULL
cells	NULL
.	NULL

An	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
complex	NULL
in	NULL
either	NULL
cell	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
concluded	NULL
that	NULL
C/EBP	NULL
a	NULL
and	NULL
-	NULL
#	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
C/EBP	NULL
motif	NULL
,	NULL
and	NULL
that	NULL
C/EBPa	NULL
bound	NULL
to	NULL
the	NULL
motif	NULL
in	NULL
THP-1	NULL
cells	NULL
and	NULL
C/EBP	NULL
/	NULL
}	NULL
bound	NULL
to	NULL
that	NULL
in	NULL
the	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
to	NULL
examine	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
C/EBP	NULL
motif	NULL
,	NULL
we	NULL
transfected	NULL
several	NULL
constructed	NULL
luciferase	NULL
reporter	NULL
DNAs	NULL
into	NULL
HL-60	NULL
cells	NULL
and	NULL
THP	NULL
-1	NULL
cells	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
C/EBP	NULL
motif	NULL
in	NULL
HL-60	NULL
cells	NULL
was	NULL
increased	NULL
by	NULL
VD	NULL
;	NULL
treatment	NULL
.	NULL

The	NULL
C/EBP	NULL
motif	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
was	NULL
confirmed	NULL
to	NULL
function	NULL
as	NULL
a	NULL
regulatory	NULL
region	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
and	NULL
THP-1	NULL
cells	NULL
by	NULL
the	NULL
assay	NULL
.	NULL

Since	NULL
C/EBP	NULL
/	NULL
}	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
VD	NULL
;	NULL
-untreated	NULL
HL-60	NULL
cells	NULL
by	NULL
immunoblotting	NULL
,	NULL
VD	NULL
,	NULL
;	NULL
activated	NULL
C/EBP	NULL
#	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
motif	NULL
,	NULL
probably	NULL
through	NULL
post-translational	NULL
modification	NULL
.	NULL

Myeloid	NULL
calcium	NULL
binding	NULL
proteins	NULL
,	NULL
MRP8	NULL
and	NULL
MRP14	NULL
(	NULL
25	NULL
,	NULL
35	NULL
)	NULL
,	NULL
also	NULL
designated	NULL
cystic	NULL
fibrosis	NULL
antigen	NULL
(	NULL
5	NULL
,	NULL
12	NULL
)	NULL
,	NULL
the	NULL
leukocyte	NULL
L1	NULL
molecule	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
60B8	NULL
antigen	NULL
(	NULL
34	NULL
,	NULL
55	NULL
)	NULL
,	NULL
p8/p14	NULL
(	NULL
17	NULL
)	NULL
,	NULL
calgranulin	NULL
A/B	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
calprotectin	NULL
(	NULL
51	NULL
,	NULL
66	NULL
)	NULL
,	NULL
are	NULL
members	NULL
of	NULL
the	NULL
$	NULL
100	NULL
protein	NULL
family	NULL
,	NULL
whose	NULL
genes	NULL
are	NULL
known	NULL
to	NULL
be	NULL
localized	NULL
in	NULL
the	NULL
cluster	NULL
on	NULL
human	NULL
chromosome	NULL
1q21	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
MRP8	NULL
and	NULL
MRP	NULL
14	NULL
be	NULL
called	NULL
$	NULL
100A¥8	NULL
and	NULL
$	NULL
100A9	NULL
,	NULL
respectively	NULL
(	NULL
46	NULL
)	NULL
.	NULL

They	NULL
are	NULL
expressed	NULL
in	NULL
myeloid	NULL
lineage	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
34	NULL
)	NULL
and	NULL
in	NULL
certain	NULL
epithelial	NULL
cells	NULL
(	NULL
63	NULL
,	NULL
68	NULL
)	NULL
.	NULL

MRP8	NULL
and	NULL
MRP14	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
normal	NULL
macrophages	NULL
but	NULL
are	NULL
detected	NULL
in	NULL
macrophages	NULL
that	NULL
have	NULL
infiltrated	NULL
into	NULL
inflammatory	NULL
lesions	NULL
(	NULL
35	NULL
,	NULL
40	NULL
,	NULL
43	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
MRP8	NULL
and	NULL
MRP14	NULL
in	NULL
such	NULL
macrophages	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
11	NULL
,	NULL
68	NULL
)	NULL
,	NULL
proba-	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
:	NULL
+81-54-264-5554	NULL
,	NULL
-	NULL
Fax	NULL
:	NULL
+81-54-264-5553	NULL
E-mail	NULL
:	NULL
kuruto	NULL
@	NULL
fns1.u-shizuoka-ken.ac.jp	NULL
Abbreviations	NULL
:	NULL
VD	NULL
;	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
;	NULL
C/EBP	NULL
,	NULL
CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
GFP	NULL
,	NULL
green	NULL
fluorescent	NULL
protein	NULL
;	NULL
MAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
.	NULL

109	NULL
bly	NULL
reflecting	NULL
the	NULL
clinical	NULL
manifestation	NULL
of	NULL
inflammatory	NULL
diseases	NULL
.	NULL

MRP	NULL
proteins	NULL
are	NULL
also	NULL
essential	NULL
as	NULL
a	NULL
diagnostic	NULL
marker	NULL
being	NULL
abundant	NULL
in	NULL
serum	NULL
of	NULL
patients	NULL
with	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
such	NULL
as	NULL
cystic	NULL
fibrosis	NULL
(	NULL
CF	NULL
)	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
other	NULL
connective	NULL
tissue	NULL
diseases	NULL
(	NULL
5	NULL
,	NULL
14	NULL
,	NULL
23	NULL
)	NULL
and	NULL
with	NULL
hematological	NULL
disorders	NULL
such	NULL
as	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
feces	NULL
of	NULL
certain	NULL
colon	NULL
cancer	NULL
patients	NULL
(	NULL
13	NULL
,	NULL
42	NULL
)	NULL
.	NULL

MRPs	NULL
are	NULL
induced	NULL
in	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
HL-60	NULL
cells	NULL
that	NULL
have	NULL
differentiated	NULL
into	NULL
macro-phage-like	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
VD	NULL
;	NULL
)	NULL
(	NULL
34	NULL
,	NULL
55	NULL
)	NULL
.	NULL

The	NULL
MRP8	NULL
and	NULL
MRP14	NULL
mRNAs	NULL
were	NULL
co-transcribed	NULL
starting	NULL
one	NULL
day	NULL
after	NULL
VD	NULL
;	NULL
treatment	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
level	NULL
reached	NULL
a	NULL
peak	NULL
on	NULL
day	NULL
two	NULL
and	NULL
then	NULL
quickly	NULL
declined	NULL
.	NULL

We	NULL
have	NULL
investigated	NULL
how	NULL
the	NULL
expressions	NULL
of	NULL
MRP8	NULL
and	NULL
MRP14	NULL
genes	NULL
are	NULL
co-expressed	NULL
.	NULL

Roth	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
a	NULL
cal-cium-induced	NULL
suppressor	NULL
protein	NULL
was	NULL
responsible	NULL
for	NULL
suppression	NULL
of	NULL
MRP8	NULL
and	NULL
MRP14	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
44	NULL
)	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
differentia-	NULL
tion-specific	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
5'-upstream	NULL
regions	NULL
of	NULL
MRP8	NULL
and	NULL
MRP	NULL
14	NULL
genes	NULL
were	NULL
identified	NULL
,	NULL
together	NULL
with	NULL
consensus	NULL
sequences	NULL
for	NULL
several	NULL
known	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
in	NULL
these	NULL
regions	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
aimed	NULL
to	NULL
examine	NULL
where	NULL
the	NULL
promoter	NULL
elements	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
were	NULL
located	NULL
and	NULL
what	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
these	NULL
elements	NULL
.	NULL

Two	NULL
DNA	NULL
fragments	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
MRP	NULL
14	NULL
gene	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
factors	NULL
that	NULL
bound	NULL
to	NULL
these	NULL
fragments	NULL
were	NULL
detected	NULL
by	NULL
the	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
.	NULL

A	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
-binding	NULL
motif	NULL
(	NULL
-81	NULL
)	NULL
of	NULL
a	NULL
fragment	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
VD	NULL
;	NULL
-in-duced	NULL
differentiation	NULL
.	NULL

C/EBP	NULL
family	NULL
is	NULL
a	NULL
basic	NULL
leucine	NULL
zipper	NULL
transcriptional	NULL
factor	NULL
and	NULL
has	NULL
several	NULL
members	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
26	NULL
,	NULL
41	NULL
)	NULL
.	NULL

C/EBPa	NULL
and	NULL
-8	NULL
are	NULL
reported	NULL
to	NULL
recognize	NULL
the	NULL
same	NULL
nucleotide	NULL
sequence	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
identified	NULL
that	NULL
the	NULL
binding	NULL
factor	NULL
was	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
,	NULL
C/EBPa	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
THP	NULL
cells	NULL
,	NULL
which	NULL
constitutively	NULL
expressed	NULL
MRP	NULL
pro-teins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
culture	NULL
Human	NULL
promyelocytic	NULL
HL-60	NULL
,	NULL
monocytic	NULL
THP	NULL
-1	NULL
,	NULL
promonocytic	NULL
U-937	NULL
,	NULL
and	NULL
monoblastic	NULL
ML-1	NULL
leukemia	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
F12	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inacti-vated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
(	NULL
Bioserum	NULL
,	NULL
Australia	NULL
)	NULL
and	NULL
100	NULL
ug/ral	NULL
each	NULL
of	NULL
sodium	NULL
ampicillin	NULL
and	NULL
kanamycin	NULL
sulfate	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
incubator	NULL
.	NULL

The	NULL
HL-60	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
107	NULL
``	NULL
M	NULL
VD	NULL
;	NULL
,	NULL
(	NULL
Chugai	NULL
Pharmaceutical	NULL
Co.	NULL
Ltd.	NULL
,	NULL
Tokyo	NULL
)	NULL
for	NULL
up	NULL
to	NULL
6	NULL
days	NULL
with	NULL
the	NULL
medium	NULL
renewed	NULL
every	NULL
3	NULL
days	NULL
.	NULL

THP	NULL
-1	NULL
and	NULL
U-937	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resources	NULL
Bank	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cells	NULL
by	NULL
the	NULL
guanidini-um/cesium	NULL
chloride	NULL
method	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
was	NULL
performed	NULL
using	NULL
P-labeled	NULL
MRP8	NULL
,	NULL
MRP14	NULL
,	NULL
and	NULL
$	NULL
-actin	NULL
cDNA	NULL
probes	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

R.	NULL
Kuruto-Niwa	NULL
et	NULL
al	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
analysis	NULL
The	NULL
5	NULL
``	NULL
-upstream	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
(	NULL
sequences	NULL
from	NULL
-1,000	NULL
to	NULL
+50	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
,	NULL
using	NULL
a	NULL
sense	NULL
primer	NULL
;	NULL
S-ATCACTGTGGAGTAGGGGAA-3	NULL
'	NULL
and	NULL
an	NULL
antisense	NULL
primer	NULL
;	NULL
5-GGGAAGCTGGCAGCTCACTT-3	NULL
'	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
MRP14	NULL
gene	NULL
fragment	NULL
was	NULL
then	NULL
cleaved	NULL
with	NULL
Sac	NULL
I	NULL
and	NULL
Hae	NULL
II	NULL
(	NULL
Takara	NULL
Biomedicals	NULL
,	NULL
Kyoto	NULL
)	NULL
into	NULL
251	NULL
bp	NULL
(	NULL
-400	NULL
to	NULL
-150	NULL
)	NULL
and	NULL
199	NULL
bp	NULL
(	NULL
-149	NULL
to	NULL
+50	NULL
)	NULL
fragments	NULL
,	NULL
which	NULL
are	NULL
designated	NULL
£251	NULL
and	NULL
£199	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
fragments	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
electrophoresis	NULL
on	NULL
DEAE	NULL
cellulose	NULL
membrane	NULL
(	NULL
S	NULL
&	NULL
S	NULL
,	NULL
Dassel	NULL
,	NULL
F.R.G	NULL
.	NULL
)	NULL

(	NULL
45	NULL
)	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
for	NULL
the	NULL
gel	NULL
mobility-shift	NULL
analysis	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
IRF-1	NULL
(	NULL
half-site	NULL
)	NULL
,	NULL
Spl	NULL
,	NULL
or	NULL
C/EBP	NULL
element	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
each	NULL
complementary	NULL
oligomer	NULL
were	NULL
synthesized	NULL
and	NULL
annealed	NULL
by	NULL
heating	NULL
both	NULL
oligonucleotides	NULL
at	NULL
90°C	NULL
for	NULL
2	NULL
min	NULL
and	NULL
then	NULL
at	NULL
70°C	NULL
for	NULL
10	NULL
min	NULL
followed	NULL
by	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

These	NULL
DNA	NULL
fragments	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
for	NULL
the	NULL
gel	NULL
mobility-shift	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cultured	NULL
HL-60	NULL
and	NULL
THP	NULL
-1	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
fragments	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y-2P	NULL
]	NULL
ATP	NULL
(	NULL
DuPont	NULL
,	NULL
NEN	NULL
,	NULL
F.R.G	NULL
.	NULL
)	NULL

by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Takara	NULL
Biomedicals	NULL
,	NULL
Kyoto	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
excess	NULL
amounts	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
or	NULL
herring	NULL
sperm	NULL
DNA	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
poly-clonal	NULL
rabbit	NULL
antibody	NULL
specific	NULL
to	NULL
C/EBP	NULL
,	NULL
-	NULL
$	NULL
,	NULL
or	NULL
-5	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
that	NULL
specifically	NULL
reacts	NULL
with	NULL
human	NULL
C/EBP	NULL
a	NULL
,	NULL
-	NULL
$	NULL
,	NULL
or	NULL
-8	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
that	NULL
is	NULL
non	NULL
cross-reactive	NULL
with	NULL
other	NULL
members	NULL
of	NULL
C/EBP	NULL
family	NULL
(	NULL
supplier	NULL
's	NULL
manual	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
heated	NULL
(	NULL
10	NULL
min	NULL
)	NULL
anti-C/EBP/	NULL
#	NULL
antibody	NULL
or	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
1	NULL
:	NULL
100	NULL
dilution	NULL
)	NULL
was	NULL
added	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
radiographic	NULL
image	NULL
was	NULL
analyzed	NULL
by	NULL
a	NULL
BAS2000	NULL
imaging	NULL
analyzer	NULL
(	NULL
Fuji	NULL
Film	NULL
Co.	NULL
Ltd.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
autoradio-graphs	NULL
.	NULL

Plasmids	NULL
For	NULL
the	NULL
construction	NULL
of	NULL
the	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
expression	NULL
vector	NULL
,	NULL
the	NULL
Pst	NULL
I-Sal	NULL
I1	NULL
sGFP	NULL
(	NULL
S65T	NULL
)	NULL
fragment	NULL
(	NULL
0.7	NULL
kb	NULL
)	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
Pst	NULL
I	NULL
site	NULL
and	NULL
Xho	NULL
I	NULL
site	NULL
of	NULL
the	NULL
zH3M	NULL
plasmid	NULL
containing	NULL
the	NULL
chimeric	NULL
CMV	NULL
/HIV	NULL
promoter	NULL
Table	NULL
I	NULL
.	NULL

_	NULL
OLIGONUCLEOTIDES	NULL
USED	NULL
FOR	NULL
THE	NULL
COMPETITION	NULL
ASSAY®	NULL
oligonucleotide	NULL
motif	NULL
location	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
5-ATAGAAGGGAAATGAACTAA-3	NULL
'	NULL
IRF-1	NULL
(	NULL
half	NULL
site	NULL
)	NULL
from	NULL
-235	NULL
to	NULL
-216	NULL
5-CTGTGAAGCAATCTTCCGGA-3	NULL
'	NULL
C/EBP	NULL
from	NULL
-88	NULL
to	NULL
-69	NULL
s-TTTCCTGCCCCGCCCCAGCC-3	NULL
'	NULL
Spl	NULL
from	NULL
-139	NULL
to	NULL
-120	NULL
®	NULL
The	NULL
20-mer	NULL
oligonucleotides	NULL
each	NULL
containing	NULL
a	NULL
transcription	NULL
factor-binding	NULL
element	NULL
(	NULL
underlined	NULL
)	NULL
were	NULL
synthe-sized	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
refers	NULL
to	NULL
Lagasse	NULL
and	NULL
Clerc	NULL
(	NULL
25	NULL
)	NULL
.	NULL

110	NULL
C/EBPa	NULL
and	NULL
-	NULL
$	NULL
in	NULL
MRP14	NULL
Gene	NULL
Expression	NULL
Table	NULL
IL	NULL
.	NULL

-	NULL
USED	NULL
For	NULL
THE	NULL
C/EBP	NULL
BINDING	NULL
MOTIF	NULL
Sequence	NULL
Wild	NULL
type	NULL
GATCTGTGAAGCAATCTTCCG	NULL
ACACTTCGTTAGAAGGCCTAG	NULL
Mutant	NULL
GATCTGTGAAGAACTCITCCG	NULL
ACACTTCITGAGAAGGCCTAG	NULL
®	NULL
The	NULL
mutated	NULL
substitutions	NULL
are	NULL
represented	NULL
in	NULL
boldface	NULL
.	NULL

(	NULL
3	NULL
,	NULL
9	NULL
,	NULL
16	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
designated	NULL
zH3M-GFP	NULL
(	NULL
4.2	NULL
kb	NULL
)	NULL
.	NULL

The	NULL
zH3M-luc	NULL
plasmid	NULL
(	NULL
5.4	NULL
kb	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
luciferase	NULL
cDNA	NULL
(	NULL
1.9	NULL
kb	NULL
)	NULL
between	NULL
the	NULL
blunt-ended	NULL
Pst	NULL
I	NULL
site	NULL
and	NULL
the	NULL
Xho	NULL
I	NULL
site	NULL
of	NULL
the	NULL
zH3M	NULL
plasmid	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

pIGCAT-MRP14	NULL
was	NULL
constructed	NULL
by	NULL
fusing	NULL
the	NULL
PCR-amplified	NULL
MRP14	NULL
gene	NULL
(	NULL
-1,000	NULL
to	NULL
+430	NULL
)	NULL
and	NULL
pIGCAT	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
blunt-ended	NULL
Sal	NULL
I-Bal	NULL
II	NULL
fragment	NULL
including	NULL
CAT	NULL
cDNA	NULL
and	NULL
the	NULL
SV40	NULL
polyadenylation	NULL
site	NULL
of	NULL
pIGCAT-MRP14	NULL
was	NULL
replaced	NULL
by	NULL
the	NULL
blunt-ended	NULL
Hind	NULL
III-BamH	NULL
I	NULL
fragment	NULL
(	NULL
2.8	NULL
kb	NULL
)	NULL
of	NULL
zH3M-luc	NULL
,	NULL
including	NULL
luciferase	NULL
cDNA	NULL
,	NULL
pSV2	NULL
splice	NULL
and	NULL
polyadenylation	NULL
signals	NULL
.	NULL

The	NULL
resultant	NULL
plasmid	NULL
was	NULL
named	NULL
p1000-luc	NULL
(	NULL
7.8	NULL
kb	NULL
)	NULL
.	NULL

pIG-lue	NULL
was	NULL
pro-moterless	NULL
and	NULL
had	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
p1000-luc	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
,	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
6.4	NULL
kb	NULL
)	NULL
.	NULL

p73-luc	NULL
plasmid	NULL
included	NULL
the	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
from	NULL
-73	NULL
to	NULL
+430	NULL
,	NULL
which	NULL
is	NULL
the	NULL
downstream	NULL
region	NULL
than	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
.	NULL

The	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-lue	NULL
plasmid	NULL
,	NULL
which	NULL
was	NULL
defective	NULL
in	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
an	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
(	NULL
-1,000	NULL
to	NULL
-89	NULL
)	NULL
,	NULL
which	NULL
was	NULL
amplified	NULL
in	NULL
a	NULL
Thermo	NULL
Processor	NULL
(	NULL
TAITEC	NULL
)	NULL
using	NULL
a	NULL
sense	NULL
primer	NULL
;	NULL
S-ATAAAGCTTCTAGATCACTGTGGAGTAGG	NULL
GGAA-3	NULL
'	NULL
and	NULL
an	NULL
antisense	NULL
primer	NULL
;	NULL
S-AAAGGATCCGTGA	NULL
GCAGTGTGGTAATGCT-3	NULL
'	NULL
,	NULL
into	NULL
the	NULL
p73-luc	NULL
plasmid	NULL
.	NULL

Mono-mers	NULL
and	NULL
multimers	NULL
(	NULL
three	NULL
copies	NULL
)	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
mutated	NULL
C/EBP	NULL
oligonucleotides	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
p73-lue	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Transfections	NULL
Cells	NULL
were	NULL
resuspended	NULL
at	NULL
1	NULL
%	NULL
10/200	NULL
wl	NULL
in	NULL
serum-free	NULL
F12	NULL
medium	NULL
(	NULL
pH	NULL
7.2	NULL
with	NULL
NaOH	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
FBS	NULL
was	NULL
added	NULL
to	NULL
10	NULL
%	NULL
.	NULL

Twenty-five	NULL
micrograms	NULL
of	NULL
luc	NULL
plasmid	NULL
DNA	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
zH3M-	NULL
$	NULL
-gal	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
herring	NULL
sperm	NULL
DNA	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
1/10	NULL
TE	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
suspension	NULL
in	NULL
a	NULL
0.4-cm	NULL
electroporation	NULL
cuvette	NULL
(	NULL
BioRad	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
and	NULL
plasmids	NULL
were	NULL
then	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Transfection	NULL
of	NULL
THP-1	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
BioRad	NULL
gene	NULL
pulser	NULL
at	NULL
300	NULL
V	NULL
and	NULL
250	NULL
uF	NULL
.	NULL

Transfection	NULL
of	NULL
HL-60	NULL
cells	NULL
was	NULL
conducted	NULL
at	NULL
300	NULL
V	NULL
and	NULL
500	NULL
uF	NULL
.	NULL

Cuvettes	NULL
were	NULL
allowed	NULL
to	NULL
stand	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
F12	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
CO	NULL
;	NULL
incubator	NULL
.	NULL

Luciferase	NULL
and	NULL
-galactosidase	NULL
assays	NULL
Twenty-four	NULL
(	NULL
for	NULL
HL-60	NULL
cells	NULL
)	NULL
or	NULL
forty-eight	NULL
hours	NULL
(	NULL
for	NULL
THP	NULL
111	NULL
1	NULL
cells	NULL
)	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
lysis	NULL
solution	NULL
(	NULL
100	NULL
mM	NULL
potassium	NULL
phosphate	NULL
pH	NULL
7.8	NULL
,	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
assayed	NULL
using	NULL
a	NULL
PicaGene	NULL
kit	NULL
(	NULL
Toyo	NULL
ink	NULL
)	NULL
.	NULL

$	NULL
-galactosidase	NULL
activity	NULL
in	NULL
cell	NULL
extracts	NULL
,	NULL
which	NULL
had	NULL
been	NULL
preheated	NULL
at	NULL
48°C	NULL
for	NULL
50	NULL
minutes	NULL
to	NULL
inactivate	NULL
endogenous	NULL
$	NULL
-galactosidase	NULL
activity	NULL
(	NULL
65	NULL
)	NULL
,	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
Galacto-Light	NULL
chemiluminescent	NULL
reporter	NULL
assay	NULL
kit	NULL
(	NULL
Tropix	NULL
,	NULL
Inc.	NULL
)	NULL
in	NULL
order	NULL
to	NULL
normalize	NULL
the	NULL
transfection	NULL
efficiency	NULL
in	NULL
each	NULL
experiment	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HL-60	NULL
,	NULL
THP	NULL
U-937	NULL
,	NULL
and	NULL
ML-1	NULL
cells	NULL
and	NULL
after	NULL
being	NULL
subjected	NULL
to	NULL
SDS-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
under	NULL
reduced	NULL
condi-tions	NULL
,	NULL
were	NULL
electrotransfered	NULL
to	NULL
a	NULL
PVDF	NULL
membrane	NULL
,	NULL
Trans-Blot	NULL
(	NULL
BioRad	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
anti-C/EBP	NULL
/	NULL
or	NULL
-a	NULL
antibody	NULL
,	NULL
or	NULL
normal	NULL
rabbit	NULL
serum	NULL
followed	NULL
by	NULL
alkaline	NULL
phosphatase	NULL
immunostaining	NULL
with	NULL
NBT	NULL
(	NULL
nitro	NULL
blue	NULL
tetrazolium	NULL
)	NULL
and	NULL
BCIP	NULL
(	NULL
5-bromo-4-chloro-3-indolyl	NULL
phos-phate	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
MRP14	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
We	NULL
examined	NULL
the	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
lines	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
MRP14	NULL
,	NULL
MRPS8	NULL
and	NULL
S-actin	NULL
cDNA	NULL
as	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

MRP14	NULL
mRNA	NULL
was	NULL
not	NULL
expressed	NULL
in	NULL
HL-60	NULL
cells	NULL
but	NULL
was	NULL
induced	NULL
in	NULL
the	NULL
cells	NULL
after	NULL
VD	NULL
;	NULL
treatment	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

No	NULL
MRP14	NULL
mRNA	NULL
was	NULL
also	NULL
detected	NULL
either	NULL
in	NULL
ML-1	NULL
or	NULL
U-937	NULL
cells	NULL
,	NULL
while	NULL
THP-1	NULL
cells	NULL
constitutively	NULL
expressed	NULL
the	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Its	NULL
level	NULL
in	NULL
THP-1	NULL
cells	NULL
was	NULL
54	NULL
%	NULL
of	NULL
that	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
scanning	NULL
by	NULL
a	NULL
densitometer	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
MRP8	NULL
mRNA	NULL
expression	NULL
was	NULL
identical	NULL
with	NULL
that	NULL
of	NULL
MRP	NULL
14	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
of	NULL
C/EBP	NULL
family	NULL
binds	NULL
to	NULL
the	NULL
5	NULL
-up-stream	NULL
region	NULL
of	NULL
MRP14	NULL
gene	NULL
To	NULL
examine	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
MRP14	NULL
gene	NULL
,	NULL
we	NULL
surveyed	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
known	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
5-upstream	NULL
region	NULL
(	NULL
-400	NULL
to	NULL
+50	NULL
)	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
binding	NULL
sites	NULL
for	NULL
three	NULL
transcription	NULL
factors	NULL
(	NULL
IRF-1	NULL
half-site	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
C/EBP	NULL
)	NULL
were	NULL
found	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
which	NULL
transcription	NULL
factor	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
MRP14	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
,	NULL
two	NULL
DNA	NULL
fragments	NULL
[	NULL
-400	NULL
to	NULL
-=150	NULL
(	NULL
£251	NULL
fragment	NULL
)	NULL
and	NULL
-149	NULL
to	NULL
+50	NULL
(	NULL
£199	NULL
fragment	NULL
)	NULL
]	NULL
were	NULL
prepared	NULL
as	NULL
probes	NULL
and	NULL
we	NULL
performed	NULL
competition	NULL
gel	NULL
shift	NULL
experiments	NULL
using	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
IRF-1	NULL
(	NULL
half-site	NULL
)	NULL
,	NULL
Sp1	NULL
,	NULL
or	NULL
C/EBP	NULL
binding	NULL
elements	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

a	NULL
%	NULL
$	NULL
9	NULL
C	NULL
pe	NULL
*	NULL
a	NULL
o	NULL
*	NULL
-n	NULL
_	NULL
8	NULL
2	NULL
w	NULL
g	NULL
9	NULL
~	NULL
C	NULL
4	NULL
4	NULL
-	NULL
T	NULL
9	NULL
-	NULL
0	NULL
0	NULL
I	NULL
|-	NULL
3	NULL
2	NULL
2	NULL
2	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
MRP-14	NULL
and	NULL
-8	NULL
mRNA	NULL
in	NULL
human	NULL
leukemia	NULL
and	NULL
peripheral	NULL
blood	NULL
cells	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
extracted	NULL
from	NULL
untreated	NULL
and	NULL
VD	NULL
;	NULL
-treated	NULL
(	NULL
day	NULL
2	NULL
)	NULL
HL-60	NULL
cells	NULL
,	NULL
and	NULL
THP-1	NULL
,	NULL
U-937	NULL
,	NULL
ML-1	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
neutrophils	NULL
was	NULL
hybridized	NULL
with	NULL
(	NULL
A	NULL
)	NULL
MRP14	NULL
cDNA	NULL
probe	NULL
,	NULL
(	NULL
B	NULL
)	NULL
MRP8	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
(	NULL
C	NULL
)	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
.	NULL

An	NULL
excess	NULL
amount	NULL
of	NULL
a	NULL
20-mer	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
IRF-1	NULL
half-sites	NULL
could	NULL
not	NULL
compete	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
£251	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
no	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
region	NULL
from	NULL
-235	NULL
to	NULL
-216	NULL
with	NULL
the	NULL
IRF-1	NULL
half-sites	NULL
in	NULL
the	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
binding	NULL
to	NULL
the	NULL
£199	NULL
probe	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
20-mer	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Spl	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
factor	NULL
of	NULL
C/EBP	NULL
family	NULL
binds	NULL
to	NULL
£199	NULL
.	NULL

Differential	NULL
binding	NULL
of	NULL
C/EBP	NULL
}	NULL
in	NULL
HL-60	NULL
and	NULL
C/EBP	NULL
a	NULL
in	NULL
THP	NULL
cells	NULL
to	NULL
the	NULL
C/EBP	NULL
motif	NULL
in	NULL
the	NULL
5-upstream	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
To	NULL
further	NULL
characterize	NULL
the	NULL
nuclear	NULL
factors	NULL
,	NULL
the	NULL
20-mer	NULL
oligonucleotide	NULL
with	NULL
the	NULL
C/EBP	NULL
element	NULL
(	NULL
C/EBP	NULL
probe	NULL
)	NULL
instead	NULL
of	NULL
£199	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
VD	NULL
;	NULL
,	NULL
for	NULL
indicated	NULL
days	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
C/EBP	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
C/EBP	NULL
probe	NULL
did	NULL
not	NULL
exist	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
untreated	NULL
HL-60	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
HL-60	NULL
cells	NULL
one	NULL
day	NULL
after	NULL
the	NULL
VD	NULL
;	NULL
treatment	NULL
.	NULL

The	NULL
factor	NULL
was	NULL
most	NULL
abundant	NULL
in	NULL
the	NULL
nuclei	NULL
on	NULL
day	NULL
3	NULL
and	NULL
had	NULL
decreased	NULL
greatly	NULL
by	NULL
day	NULL
6	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
factor	NULL
is	NULL
112	NULL
R.	NULL
Kuruto-Niwa	NULL
et	NULL
al	NULL
.	NULL

A	NULL
MRP14	NULL
IRF-1	NULL
(	NULL
haif-site	NULL
)	NULL
-	NULL
Spi	NULL
C/EBP	NULL
exon	NULL
1	NULL
400	NULL
231	NULL
-226	NULL
~149-133	NULL
-81	NULL
Fet	NULL
--	NULL
--	NULL
{	NULL
251	NULL
probe	NULL
.	NULL

.	NULL

--	NULL
--	NULL
-i-r	NULL
#	NULL
--	NULL
--	NULL
-	NULL
£199	NULL
probe	NULL
--	NULL
-i®i	NULL
ri	NULL
£	NULL
<	NULL
4	NULL
Z	NULL
a	NULL
E	NULL
>	NULL
U	NULL
Im	NULL
o.	NULL
a	NULL
€	NULL
-	NULL
&	NULL
a	NULL
-	NULL
._	NULL
a	NULL
Eou	NULL
.	NULL

g	NULL
5	NULL
k	NULL
3	NULL
2	NULL
&	NULL
8	NULL
L	NULL
+	NULL
+	NULL
_J	NULL
t	NULL
+	NULL
+	NULL
TC	NULL
ITC	NULL
-	NULL
>	NULL
tree	NULL
probe	NULL
-	NULL
>	NULL
1	NULL
2	NULL
3	NULL
40	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Gel	NULL
mobility-shift	NULL
assays	NULL
for	NULL
the	NULL
MRP14	NULL
gene	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
VD	NULL
;	NULL
for	NULL
1	NULL
day	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Location	NULL
of	NULL
elements	NULL
for	NULL
some	NULL
transcription	NULL
factors	NULL
(	NULL
24	NULL
)	NULL
in	NULL
the	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
mobility-shift	NULL
analysis	NULL
using	NULL
the	NULL
251	NULL
bp	NULL
fragment	NULL
(	NULL
£251	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Herring	NULL
sperm	NULL
DNA	NULL
and	NULL
an	NULL
oligonucleotide	NULL
with	NULL
the	NULL
IRF-1	NULL
half-sites	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
(	NULL
100	NULL
ng	NULL
,	NULL
1300-fold	NULL
molar	NULL
excess	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel	NULL
mobility-shift	NULL
analysis	NULL
using	NULL
the	NULL
199	NULL
bp	NULL
fragment	NULL
(	NULL
£199	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Herring	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
oligonucleotides	NULL
with	NULL
the	NULL
Sp1-	NULL
or	NULL
C/EBP	NULL
-binding	NULL
motif	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
(	NULL
50	NULL
ng	NULL
,	NULL
500-fold	NULL
molar	NULL
excess	NULL
)	NULL
.	NULL

An	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
shifted	NULL
band	NULL
.	NULL

differentiation-dependent	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
factor	NULL
to	NULL
the	NULL
C/EBP	NULL
probe	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
unlabeled	NULL
C/EBP	NULL
probe	NULL
but	NULL
not	NULL
by	NULL
the	NULL
Spl	NULL
oligonucleotide	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
factor	NULL
bound	NULL
specifically	NULL
to	NULL
the	NULL
C/EBP	NULL
motif	NULL
.	NULL

The	NULL
shifted	NULL
band	NULL
was	NULL
also	NULL
present	NULL
in	NULL
THP	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
which	NULL
member	NULL
of	NULL
C/EBP	NULL
transcriptional	NULL
factor	NULL
binds	NULL
to	NULL
the	NULL
motif	NULL
,	NULL
the	NULL
nucleoprotein	NULL
complex	NULL
was	NULL
incubated	NULL
with	NULL
anti-C/EBPa	NULL
,	NULL
-	NULL
$	NULL
,	NULL
or	NULL
-5	NULL
antibody	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
this	NULL
specific	NULL
complex	NULL
in	NULL
VD	NULL
;	NULL
C/EBP	NULL
a	NULL
and	NULL
-	NULL
$	NULL
in	NULL
MRP14	NULL
Gene	NULL
Expression	NULL
a	NULL
&	NULL
A	NULL
o	NULL
B	NULL
a	NULL
o	NULL
L4	NULL
a	NULL
<	NULL
og	NULL
&	NULL
w	NULL
&	NULL
Im	NULL
a	NULL
I	NULL
Im	NULL
(	NULL
8ng	NULL
-	NULL
G	NULL
v=	NULL
©	NULL
o	NULL
o	NULL
a	NULL
fA	NULL
a	NULL
a	NULL
OA	NULL
a	NULL
o	NULL
a	NULL
o	NULL
a	NULL
o	NULL
®	NULL
o	NULL
a	NULL
Q	NULL
+	NULL
+	NULL
§	NULL
+	NULL
+	NULL
§	NULL
+	NULL
+	NULL
gd	NULL
3	NULL
4	NULL
3	NULL
-	NULL
T	NULL
IC	NULL
J	NULL
-L	NULL
E	NULL
|=	NULL
+	NULL
cp	NULL
+	NULL
Sp1	NULL
HL-60	NULL
Day	NULL
3	NULL
THP-1	NULL
Cell	NULL
-	NULL
a	NULL
B	NULL
8	NULL
-	NULL
a	NULL
B	NULL
8	NULL
Antibody	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Gel	NULL
mobility-shift	NULL
assays	NULL
for	NULL
the	NULL
C/EBP	NULL
motif	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
.	NULL

The	NULL
20-mer	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Competition	NULL
analysis	NULL
with	NULL
the	NULL
cold	NULL
(	NULL
unlabeled	NULL
)	NULL
DNA	NULL
probe	NULL
and	NULL
Sp1	NULL
oligonucleotide	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
VD	NULL
;	NULL
for	NULL
0	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
days	NULL
(	NULL
A	NULL
)	NULL
and	NULL
THP-1	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel	NULL
mobility-shift	NULL
assays	NULL
with	NULL
the	NULL
anti-C/EBPa	NULL
(	NULL
a	NULL
)	NULL
,	NULL
anti-C/EBP	NULL
$	NULL
(	NULL
§	NULL
)	NULL
,	NULL
or	NULL
anti-C/EBPé	NULL
(	NULL
6	NULL
)	NULL
antibody	NULL
.	NULL

An	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
shifted	NULL
band	NULL
.	NULL

treated	NULL
HL-60	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
anti-C/EBP/	NULL
#	NULL
antibody	NULL
,	NULL
but	NULL
not	NULL
affected	NULL
by	NULL
either	NULL
anti-C/EBPa	NULL
or	NULL
-5	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
heated	NULL
(	NULL
100°C	NULL
,	NULL
10	NULL
min	NULL
)	NULL
anti-C/EBP	NULL
}	NULL
antibody	NULL
,	NULL
or	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
nucleoprotein	NULL
complex	NULL
in	NULL
THP	NULL
-1	NULL
cells	NULL
was	NULL
supershifted	NULL
by	NULL
an	NULL
anti-C/EBPa	NULL
antibody	NULL
instead	NULL
of	NULL
an	NULL
anti-C/EBP	NULL
$	NULL
antibody	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
complex	NULL
contains	NULL
C/EBP/	NULL
#	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
and	NULL
C/EBPa	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
U-937	NULL
cells	NULL
,	NULL
which	NULL
did	NULL
not	NULL
express	NULL
MRP14	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
weak	NULL
shifted	NULL
band	NULL
was	NULL
detected	NULL
and	NULL
the	NULL
formation	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
anti-C/EBPa	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
nuclear	NULL
complex	NULL
was	NULL
found	NULL
in	NULL
ML-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
To	NULL
characterize	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
,	NULL
luc	NULL
plasmid	NULL
DNA	NULL
was	NULL
transfected	NULL
into	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
VD	NULL
;	NULL
,	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

We	NULL
preliminarily	NULL
tested	NULL
the	NULL
transfection	NULL
efficiencies	NULL
of	NULL
zH3M-GFP	NULL
into	NULL
HL-60	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
since	NULL
HL-60	NULL
cells	NULL
are	NULL
suspected	NULL
to	NULL
have	NULL
a	NULL
low	NULL
transfection	NULL
efficiency	NULL
(	NULL
38	NULL
)	NULL
.	NULL

zH3M-GFP	NULL
,	NULL
which	NULL
includes	NULL
a	NULL
visual	NULL
reporter	NULL
,	NULL
GFP	NULL
(	NULL
7	NULL
)	NULL
,	NULL
was	NULL
poorly	NULL
trans-	NULL
113	NULL
fected	NULL
by	NULL
electroporation	NULL
into	NULL
HL-60	NULL
cells	NULL
compared	NULL
with	NULL
THP	NULL
-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
poor	NULL
transfection	NULL
of	NULL
HL-60	NULL
cells	NULL
was	NULL
also	NULL
shown	NULL
by	NULL
the	NULL
S-galactosidase	NULL
assay	NULL
using	NULL
the	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
serum	NULL
(	NULL
10	NULL
%	NULL
)	NULL
to	NULL
the	NULL
electroporation	NULL
medium	NULL
improved	NULL
the	NULL
transfection	NULL
efficiency	NULL
of	NULL
HL-60	NULL
cells	NULL
up	NULL
to	NULL
10	NULL
%	NULL
of	NULL
that	NULL
of	NULL
THP	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
following	NULL
luciferase	NULL
assays	NULL
of	NULL
THP	NULL
-1	NULL
cells	NULL
were	NULL
performed	NULL
in	NULL
serum-free	NULL
electroporation	NULL
medium	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
HL-60	NULL
cells	NULL
was	NULL
done	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
serum	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
HL-60	NULL
cells	NULL
were	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

We	NULL
constructed	NULL
the	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-luc	NULL
that	NULL
was	NULL
defective	NULL
in	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
,	NULL
in	NULL
order	NULL
to	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
the	NULL
motif	NULL
by	NULL
comparison	NULL
with	NULL
p1000-luec	NULL
.	NULL

The	NULL
luc	NULL
activity	NULL
of	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-lue	NULL
was	NULL
decreased	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
p1000-luc	NULL
[	NULL
Fig	NULL
.	NULL

5A¥	NULL
(	NULL
a	NULL
)	NULL
]	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
C/EBP	NULL
motif	NULL
was	NULL
a	NULL
positive	NULL
functional	NULL
regulatory	NULL
region	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
.	NULL

In	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
luc	NULL
activity	NULL
of	NULL
p1000-lue	NULL
was	NULL
approximately	NULL
1.5-fold	NULL
greater	NULL
than	NULL
in	NULL
the	NULL
untreated	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
C/EBP	NULL
motif	NULL
,	NULL
single	NULL
and	NULL
multimerized	NULL
,	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
C/EBP	NULL
oligonucleotides	NULL
were	NULL
fused	NULL
in	NULL
the	NULL
ordinary	NULL
(	NULL
sense	NULL
)	NULL
or	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Expression	NULL
of	NULL
GFP	NULL
in	NULL
HL-60	NULL
(	NULL
A	NULL
)	NULL
and	NULL
THP-1	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
electroporated	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
plasmid	NULL
DNA	NULL
construct	NULL
carrying	NULL
sGFP	NULL
(	NULL
S65T	NULL
)	NULL
.	NULL

The	NULL
GFP	NULL
in	NULL
transfected	NULL
cells	NULL
was	NULL
visualized	NULL
after	NULL
48	NULL
h	NULL
incubation	NULL
using	NULL
a	NULL
fluorescence	NULL
microscope	NULL
under	NULL
blue	NULL
light	NULL
(	NULL
490	NULL
nm	NULL
)	NULL
.	NULL

Bar=100	NULL
wm	NULL
.	NULL

opposite	NULL
direction	NULL
(	NULL
antisense	NULL
)	NULL
to	NULL
p73-luc	NULL
construct	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
assayed	NULL
[	NULL
Fig	NULL
.	NULL

5A¥	NULL
(	NULL
b	NULL
)	NULL
]	NULL
.	NULL

The	NULL
p73-luc	NULL
plasmid	NULL
that	NULL
was	NULL
fused	NULL
with	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
sense	NULL
C/EBP	NULL
motif	NULL
(	NULL
C/EBP-p73-luc	NULL
)	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
had	NULL
3-	NULL
to	NULL
4-fold	NULL
higher	NULL
activity	NULL
than	NULL
that	NULL
in	NULL
the	NULL
untreated	NULL
cells	NULL
,	NULL
and	NULL
5-fold	NULL
higher	NULL
activity	NULL
than	NULL
p73-luc	NULL
(	NULL
without	NULL
the	NULL
C/EBP	NULL
motif	NULL
)	NULL
in	NULL
the	NULL
VD	NULL
;	NULL
-treated	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
the	NULL
insertion	NULL
of	NULL
an	NULL
antisense	NULL
copy	NULL
.	NULL

Introduction	NULL
of	NULL
a	NULL
two-base	NULL
pair	NULL
mutation	NULL
in	NULL
either	NULL
C/EBP	NULL
motif	NULL
lowered	NULL
the	NULL
luc	NULL
activity	NULL
in	NULL
both	NULL
cells	NULL
.	NULL

Three	NULL
copies	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
sense	NULL
C/EBP	NULL
oligonucleotide	NULL
increased	NULL
the	NULL
activity	NULL
to	NULL
approximately	NULL
3-fold	NULL
by	NULL
VD	NULL
;	NULL
treatment	NULL
,	NULL
and	NULL
8-fold	NULL
that	NULL
of	NULL
the	NULL
p73-luc	NULL
in	NULL
the	NULL
VD	NULL
;	NULL
-treated	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
antisense	NULL
C/EBP	NULL
motif	NULL
as	NULL
well	NULL
as	NULL
the	NULL
mutation	NULL
had	NULL
no	NULL
so	NULL
stimulatory	NULL
effect	NULL
.	NULL

In	NULL
untreated	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
C/EBP	NULL
motif	NULL
raised	NULL
the	NULL
luciferase	NULL
activity	NULL
to	NULL
a	NULL
certain	NULL
extent	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

It	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
artificial	NULL
event	NULL
that	NULL
with	NULL
low	NULL
affinity	NULL
showed	NULL
the	NULL
activity	NULL
by	NULL
the	NULL
transfection	NULL
of	NULL
multicopy	NULL
DNA	NULL
,	NULL
because	NULL
C/EBP	NULL
#	NULL
was	NULL
114	NULL
R.	NULL
Kuruto-Niwa	NULL
et	NULL
al	NULL
.	NULL

detected	NULL
in	NULL
untreated	NULL
HL-60	NULL
cells	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
below	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
luc	NULL
activity	NULL
of	NULL
p1000-lue	NULL
was	NULL
a	NULL
half	NULL
of	NULL
that	NULL
of	NULL
C/EBP-p73-lue	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
might	NULL
be	NULL
silencer	NULL
elements	NULL
in	NULL
the	NULL
other	NULL
region	NULL
except	NULL
the	NULL
C/EBP	NULL
motif	NULL
in	NULL
the	NULL
MRP	NULL
14	NULL
gene	NULL
.	NULL

Fig	NULL
.	NULL

5B	NULL
showed	NULL
the	NULL
results	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
lue	NULL
activity	NULL
of	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-lue	NULL
was	NULL
decreased	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
p1000-luc	NULL
[	NULL
Fig	NULL
.	NULL

5B	NULL
(	NULL
a	NULL
)	NULL
]	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
C/EBP-p73-luc	NULL
was	NULL
3-	NULL
to	NULL
4-fold	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
p73-luc	NULL
[	NULL
Fig	NULL
.	NULL

5B	NULL
(	NULL
b	NULL
)	NULL
]	NULL
.	NULL

Moreover	NULL
,	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
sense	NULL
C/EBP	NULL
motif	NULL
increased	NULL
the	NULL
activity	NULL
to	NULL
approximately	NULL
10-fold	NULL
that	NULL
of	NULL
the	NULL
p73-luc	NULL
in	NULL
THP	NULL
-1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
was	NULL
the	NULL
functional	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
MRP14	NULL
gene	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
and	NULL
THP	NULL
-1	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
C/EBP	NULL
/	NULL
#	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
We	NULL
investigated	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
C/EBP	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
lines	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
the	NULL
anti-C/EBP/	NULL
#	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
stained	NULL
discrete	NULL
two	NULL
protein	NULL
bands	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
46	NULL
and	NULL
44	NULL
kDa	NULL
;	NULL
the	NULL
44	NULL
kDa	NULL
band	NULL
was	NULL
stained	NULL
much	NULL
stronger	NULL
by	NULL
the	NULL
antibody	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
are	NULL
considered	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
the	NULL
first	NULL
two	NULL
AUG	NULL
codons	NULL
of	NULL
mRNA	NULL
(	NULL
1	NULL
,	NULL
60	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
two	NULL
signals	NULL
did	NULL
not	NULL
significantly	NULL
change	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
VD	NULL
;	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

was	NULL
strongly	NULL
expressed	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
except	NULL
for	NULL
ML-1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
C/EBP	NULL
}	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
untreated	NULL
HL-60	NULL
cells	NULL
and	NULL
THP	NULL
cells	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
C/EBP	NULL
motif	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
,	NULL
C	NULL
)	NULL
.	NULL

With	NULL
the	NULL
anti-C/EBPa	NULL
antibody	NULL
,	NULL
no	NULL
specific	NULL
band	NULL
appeared	NULL
in	NULL
either	NULL
cell	NULL
by	NULL
the	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
band	NULL
was	NULL
detected	NULL
with	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
We	NULL
examined	NULL
MRP	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

The	NULL
MRP	NULL
genes	NULL
were	NULL
not	NULL
expressed	NULL
in	NULL
monoblastic	NULL
ML-1	NULL
cells	NULL
and	NULL
promonocytic	NULL
U-937	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
promyelocytic	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Other	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
MRPs	NULL
are	NULL
expressed	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
discrepancy	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
variations	NULL
of	NULL
U-937	NULL
phenotype	NULL
under	NULL
different	NULL
culture	NULL
conditions	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
monocytic	NULL
THP	NULL
(	NULL
58	NULL
)	NULL
and	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
expressed	NULL
the	NULL
MRP	NULL
genes	NULL
,	NULL
but	NULL
with	NULL
differential	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
MRP	NULL
genes	NULL
are	NULL
expressed	NULL
at	NULL
the	NULL
post	NULL
promonocytic	NULL
stage	NULL
in	NULL
monocytic	NULL
differentiation	NULL
and	NULL
the	NULL
VD	NULL
;	NULL
treatment	NULL
induced	NULL
the	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
beyond	NULL
the	NULL
promonocytic	NULL
stage	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
binding	NULL
of	NULL
nuclear	NULL
transcriptional	NULL
C/EBPa	NULL
and	NULL
-	NULL
$	NULL
in	NULL
MRP14	NULL
Gene	NULL
Expression	NULL
A.	NULL
HL-60	NULL
C/EBP	NULL
multimers-luc	NULL
p1000-luc	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-luc	NULL
E	NULL
p73-	NULL
Iuc	NULL
sense	NULL
C/EBP	NULL
»	NULL
--	NULL
--	NULL
-C	NULL
antisense	NULL
C/EBP	NULL
‘	NULL
___	NULL
.	NULL

@	NULL
mutated	NULL
sense	NULL
C/EBP	NULL
>	NULL
————	NULL
@	NULL
mutated	NULL
antisense	NULL
C/EBP	NULL
4—1	NULL
@	NULL
sense	NULL
C/EBP	NULL
x3	NULL
»	NULL
es	NULL
--	NULL
--	NULL
-CE	NULL
antisense	NULL
C/EBP	NULL
x3	NULL
«	NULL
————|	NULL
@	NULL
mutated	NULL
sense	NULL
C/EBP	NULL
x3	NULL
.	NULL

mutated	NULL
anti	NULL
sense	NULL
C/EBP	NULL
x3	NULL
«	NULL
n———-	NULL
@	NULL
ot	NULL
Fold	NULL
induction	NULL
iA	NULL
-~	NULL
R	NULL
Hu-so	NULL
[	NULL
A	NULL
VDg-treated	NULL
HL-60	NULL
C/EBP	NULL
multimers-luc	NULL
B.	NULL
THP-1	NULL
o	NULL
p1000-luc	NULL
p1000	NULL
{	NULL
-C/EBP	NULL
)	NULL
-lue	NULL
g	NULL
p73-ue	NULL
--	NULL
-	NULL
sense	NULL
C/EBP	NULL
>	NULL
———	NULL
&	NULL
l	NULL
antisense	NULL
C/EBP	NULL
I	NULL
:	NULL
]	NULL
mutated	NULL
sense	NULL
C/EBP	NULL
>	NULL
—————	NULL
@	NULL
mulated	NULL
antisense	NULL
C/EBP	NULL
sense	NULL
C/EBP	NULL
x3	NULL
>	NULL
»	NULL
——-	NULL
@	NULL
antisense	NULL
C/EBP	NULL
x3	NULL
m—ﬁ	NULL
mutated	NULL
sense	NULL
C/EBP	NULL
x3	NULL
.	NULL

bpp	NULL
--	NULL
--	NULL
--	NULL
LBZ	NULL
]	NULL
mutated	NULL
anti	NULL
sense	NULL
C/EBP	NULL
x3	NULL
M	NULL
»	NULL
C/EBP	NULL
motif	NULL
»	NULL
mutated	NULL
Fold	NULL
induction	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
by	NULL
luciferase	NULL
assay	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
VD	NULL
;	NULL
for	NULL
2	NULL
days	NULL
and	NULL
then	NULL
transfected	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
p73-luc	NULL
construct	NULL
in	NULL
untreated	NULL
HL-60	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
THP	NULL
-1	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
harvested	NULL
48	NULL
h	NULL
later	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
p73-lue	NULL
construct	NULL
.	NULL

The	NULL
values	NULL
are	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
;	NULL
error	NULL
sentation	NULL
of	NULL
each	NULL
luc	NULL
reporter	NULL
construct	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

(	NULL
a	NULL
)	NULL
p1000-luc	NULL
single	NULL
and	NULL
three	NULL
copies	NULL
,	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
C/EBP	NULL
oligonucleotides	NULL
.	NULL

factors	NULL
to	NULL
the	NULL
cis-element	NULL
of	NULL
a	NULL
gene	NULL
can	NULL
promote	NULL
the	NULL
initiation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
15	NULL
,	NULL
54	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
transcriptional	NULL
factors	NULL
regulating	NULL
the	NULL
MRP14	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
performed	NULL
gel-shift	NULL
competition	NULL
assay	NULL
using	NULL
two	NULL
probes	NULL
,	NULL
£251	NULL
(	NULL
-400	NULL
to	NULL
-150	NULL
)	NULL
and	NULL
£199	NULL
(	NULL
-	NULL
149	NULL
to	NULL
+50	NULL
)	NULL
in	NULL
the	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
MRP	NULL
14	NULL
gene	NULL
.	NULL

A	NULL
retarded	NULL
complex	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
which	NULL
had	NULL
been	NULL
faintly	NULL
detected	NULL
and	NULL
neglected	NULL
in	NULL
the	NULL
previous	NULL
study	NULL
(	NULL
24	NULL
)	NULL
,	NULL
was	NULL
clearly	NULL
detected	NULL
in	NULL
the	NULL
current	NULL
study	NULL
and	NULL
was	NULL
competed	NULL
with	NULL
a	NULL
C/EBP-specific	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
re-evalu-ated	NULL
the	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
C/EBP	NULL
motif	NULL
and	NULL
further	NULL
studied	NULL
in	NULL
the	NULL
following	NULL
experiments	NULL
.	NULL

A	NULL
retarded	NULL
115	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
of	NULL
the	NULL
means	NULL
.	NULL

A	NULL
schematic	NULL
repre-and	NULL
p1000	NULL
(	NULL
-C/EBP	NULL
)	NULL
-luc	NULL
construct	NULL
.	NULL

(	NULL
b	NULL
)	NULL
p73-lue	NULL
and	NULL
p73-lue	NULL
fused	NULL
with	NULL
band	NULL
close	NULL
to	NULL
the	NULL
free	NULL
£199	NULL
probe	NULL
has	NULL
been	NULL
designated	NULL
MP14FII	NULL
in	NULL
the	NULL
previous	NULL
report	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
however	NULL
,	NULL
the	NULL
band	NULL
was	NULL
not	NULL
consistently	NULL
detected	NULL
,	NULL
and	NULL
we	NULL
concluded	NULL
that	NULL
MP1I4FII	NULL
was	NULL
a	NULL
false-negative	NULL
.	NULL

In	NULL
the	NULL
previous	NULL
gel	NULL
shift	NULL
assay	NULL
,	NULL
we	NULL
designated	NULL
a	NULL
factor	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
HL-60	NULL
cells	NULL
that	NULL
retarded	NULL
the	NULL
£251	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
as	NULL
MP14FI	NULL
(	NULL
24	NULL
)	NULL
,	NULL
which	NULL
was	NULL
also	NULL
present	NULL
in	NULL
THP	NULL
-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MP14FT	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
IRF-1	NULL
half-sites	NULL
,	NULL
since	NULL
the	NULL
retardation	NULL
of	NULL
£251	NULL
by	NULL
MP14FI	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
competitor	NULL
with	NULL
the	NULL
IRF-1	NULL
half-sites	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
essential	NULL
to	NULL
determine	NULL
where	NULL
MPI4FI	NULL
binds	NULL
in	NULL
the	NULL
£251	NULL
fragment	NULL
in	NULL
future	NULL
experiments	NULL
.	NULL

Day	NULL
1	NULL
Day	NULL
3	NULL
o	NULL
>	NULL
f	NULL
o	NULL
o	NULL
©	NULL
n	NULL
al	NULL
U-937	NULL
ML-1	NULL
THP-1	NULL
44	NULL
kDa	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
C/EBP	NULL
in	NULL
human	NULL
leukemia	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
C/EBPS	NULL
from	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
VD	NULL
;	NULL
for	NULL
0	NULL
,	NULL
1	NULL
,	NULL
and	NULL
3	NULL
days	NULL
,	NULL
and	NULL
from	NULL
THP-1	NULL
,	NULL
U-937	NULL
,	NULL
and	NULL
ML-1	NULL
cells	NULL
.	NULL

Blotted	NULL
membrane	NULL
was	NULL
immunostained	NULL
with	NULL
an	NULL
anti-C/EBP	NULL
/	NULL
antibody	NULL
.	NULL

The	NULL
C/EBP-specific	NULL
binding	NULL
was	NULL
further	NULL
studied	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
C/EBP	NULL
-specific	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
gel-shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
factor	NULL
which	NULL
is	NULL
VD	NULL
;	NULL
differentiation-dependent	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
was	NULL
immunologically	NULL
identified	NULL
as	NULL
C/EBP	NULL
$	NULL
,	NULL
whereas	NULL
C/EBP	NULL
a	NULL
bound	NULL
to	NULL
the	NULL
same	NULL
C/EBP	NULL
motif	NULL
in	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

C/EBPa	NULL
,	NULL
previously	NULL
termed	NULL
C/EBP	NULL
,	NULL
was	NULL
identified	NULL
originally	NULL
as	NULL
a	NULL
heat-stable	NULL
,	NULL
sequence-specific	NULL
DNA-bind-ing	NULL
activity	NULL
present	NULL
in	NULL
soluble	NULL
extracts	NULL
of	NULL
rat	NULL
liver	NULL
nuclei	NULL
(	NULL
26	NULL
)	NULL
and	NULL
is	NULL
characterized	NULL
as	NULL
a	NULL
factor	NULL
involved	NULL
in	NULL
cell	NULL
differentiation	NULL
and	NULL
energy	NULL
metabolism	NULL
(	NULL
28	NULL
,	NULL
50	NULL
,	NULL
53	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Several	NULL
isoforms	NULL
,	NULL
such	NULL
as	NULL
C/EBP	NULL
#	NULL
,	NULL
-7	NULL
,	NULL
-8	NULL
,	NULL
-£	NULL
and	NULL
CHOP	NULL
10	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
and	NULL
they	NULL
are	NULL
known	NULL
as	NULL
the	NULL
C/EBP	NULL
family	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
10	NULL
,	NULL
26	NULL
,	NULL
41	NULL
,	NULL
54	NULL
)	NULL
.	NULL

These	NULL
members	NULL
can	NULL
cross-dimerize	NULL
and	NULL
bind	NULL
to	NULL
DNA	NULL
with	NULL
similar	NULL
specificity	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
37	NULL
,	NULL
41	NULL
,	NULL
64	NULL
)	NULL
.	NULL

C/EBP	NULL
}	NULL
is	NULL
known	NULL
to	NULL
regulate	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
normal	NULL
myeloid	NULL
development	NULL
as	NULL
well	NULL
as	NULL
to	NULL
activation	NULL
of	NULL
mature	NULL
myeloid	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
an	NULL
inflammatory	NULL
stimulus	NULL
(	NULL
1	NULL
,	NULL
31	NULL
,	NULL
39	NULL
,	NULL
52	NULL
,	NULL
53	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
C/EBP	NULL
&	NULL
increases	NULL
during	NULL
differentiation	NULL
towards	NULL
granulocytes	NULL
as	NULL
well	NULL
as	NULL
macrophages	NULL
(	NULL
31	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
binding	NULL
of	NULL
C/EBPa	NULL
and	NULL
-	NULL
$	NULL
in	NULL
our	NULL
study	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
MRPI14	NULL
expression	NULL
since	NULL
the	NULL
level	NULL
of	NULL
MRP14	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
was	NULL
half	NULL
that	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Pope	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
C/EBP	NULL
}	NULL
was	NULL
a	NULL
stronger	NULL
acti-vator	NULL
of	NULL
the	NULL
TNFa	NULL
promoter	NULL
than	NULL
C/EBP	NULL
a	NULL
(	NULL
39	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
C/EBPa	NULL
attenuated	NULL
the	NULL
transcriptional	NULL
activation	NULL
by	NULL
C/EBP	NULL
#	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activities	NULL
of	NULL
the	NULL
C/EBP	NULL
binding	NULL
motif	NULL
were	NULL
functional	NULL
and	NULL
showed	NULL
similar	NULL
patterns	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
C/EBP	NULL
synergistically	NULL
interact	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
may	NULL
bind	NULL
to	NULL
other	NULL
promoter	NULL
regions	NULL
in	NULL
the	NULL
MRP14	NULL
gene	NULL
,	NULL
for	NULL
example	NULL
,	NULL
an	NULL
unknown	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
£251	NULL
fragment	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
C/EBP	NULL
#	NULL
116	NULL
R.	NULL
Kuruto-Niwa	NULL
et	NULL
al	NULL
.	NULL

interacts	NULL
with	NULL
NF-4B	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
and	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
8	NULL
,	NULL
27	NULL
,	NULL
33	NULL
)	NULL
,	NULL
and	NULL
that	NULL
C/EBPa	NULL
asso-ciliates	NULL
with	NULL
TFIIB	NULL
,	NULL
TATA-binding	NULL
protein	NULL
,	NULL
and	NULL
AML	NULL
(	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
)	NULL
-1	NULL
(	NULL
32	NULL
,	NULL
67	NULL
)	NULL
.	NULL

The	NULL
differential	NULL
activity	NULL
of	NULL
C/EBP	NULL
isoforms	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
distinct	NULL
interactions	NULL
with	NULL
other	NULL
proteins	NULL
(	NULL
37	NULL
)	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
examine	NULL
the	NULL
other	NULL
negative	NULL
or	NULL
positive	NULL
factors	NULL
involved	NULL
in	NULL
MRP	NULL
14	NULL
expression	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
that	NULL
no	NULL
C/EBP	NULL
}	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
untreated	NULL
HL-60	NULL
and	NULL
U-937	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
however	NULL
,	NULL
C/EBP	NULL
#	NULL
was	NULL
detected	NULL
in	NULL
these	NULL
cells	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
also	NULL
due	NULL
to	NULL
different	NULL
cell	NULL
culture	NULL
conditions	NULL
as	NULL
discussed	NULL
above	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
C/EBP	NULL
}	NULL
appeared	NULL
in	NULL
HL-60	NULL
cells	NULL
after	NULL
VD	NULL
;	NULL
treatment	NULL
with	NULL
little	NULL
change	NULL
in	NULL
C/EBP	NULL
#	NULL
level	NULL
.	NULL

Other	NULL
investigators	NULL
similarly	NULL
reported	NULL
that	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
C/EBP	NULL
&	NULL
#	NULL
increased	NULL
after	NULL
stimulation	NULL
,	NULL
whereas	NULL
the	NULL
amount	NULL
of	NULL
remained	NULL
unchanged	NULL
,	NULL
suggesting	NULL
that	NULL
was	NULL
activated	NULL
through	NULL
post-translational	NULL
modification	NULL
(	NULL
1	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Similar	NULL
post-translational	NULL
modifi	NULL
cation	NULL
of	NULL
C/EBP	NULL
#	NULL
may	NULL
occur	NULL
in	NULL
VD	NULL
;	NULL
-treated	NULL
HL-60	NULL
cells	NULL
.	NULL

Several	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
C/EBP	NULL
#	NULL
is	NULL
activated	NULL
through	NULL
phosphorylation	NULL
by	NULL
calcium/cal-modulin-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
62	NULL
)	NULL
,	NULL
mitogen-activated	NULL
kinase	NULL
(	NULL
30	NULL
)	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
,	NULL
or	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
57	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
reported	NULL
that	NULL
the	NULL
association	NULL
with	NULL
c-Fos	NULL
or	NULL
with	NULL
c-Jun	NULL
altered	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
C/EBP	NULL
and	NULL
reduced	NULL
its	NULL
binding	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
identify	NULL
any	NULL
modification	NULL
in	NULL
the	NULL
HL-60	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
.	NULL

We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Dr.	NULL
Ken	NULL
Takeda	NULL
,	NULL
Showa	NULL
University	NULL
,	NULL
Tokyo	NULL
for	NULL
ML-1	NULL
cells	NULL
,	NULL
Dr.	NULL
Hiroyasu	NULL
Uchiyama	NULL
,	NULL
Hiroshima	NULL
University	NULL
,	NULL
Hiroshima	NULL
for	NULL
zH3M-	NULL
$	NULL
-gal	NULL
,	NULL
and	NULL
Dr.	NULL
Yasuo	NULL
Niwa	NULL
,	NULL
University	NULL
of	NULL
Shizuoka	NULL
for	NULL
providing	NULL
sGFP	NULL
(	NULL
S65T	NULL
)	NULL
DNA	NULL
with	NULL
the	NULL
permission	NULL
of	NULL
Dr.	NULL
Brian	NULL
Seed	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
and	NULL
helpful	NULL
suggestions	NULL
of	NULL
the	NULL
plasmid	NULL
construction	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Tetsuo	NULL
Hirano	NULL
of	NULL
Hiroshima	NULL
University	NULL
for	NULL
the	NULL
advice	NULL
on	NULL
the	NULL
transfection	NULL
experiment	NULL
and	NULL
Dr.	NULL
Kazunari	NULL
Yokoyama	NULL
,	NULL
Tsukuba	NULL
Life	NULL
Science	NULL
Center	NULL
,	NULL
RIKEN	NULL
,	NULL
for	NULL
helpful	NULL
discussions	NULL
on	NULL
the	NULL
transfection	NULL
.	NULL

REFERENCES	NULL
AxiRaA	NULL
,	NULL
S.	NULL
,	NULL
IssEnk1	NULL
,	NULL
H.	NULL
,	NULL
Svoaita	NULL
,	NULL
T.	NULL
,	NULL
TANABE	NULL
,	NULL
O.	NULL
,	NULL
KivosHitA	NULL
,	NULL
S.	NULL
,	NULL
NisH0	NULL
,	NULL
Y.	NULL
,	NULL
Nakama	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kisaimoto	NULL
,	NULL
T.	NULL
1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
:	NULL
1897-1906	NULL
.	NULL

AxIRA	NULL
,	NULL
S.	NULL
and	NULL
Kisaimoto	NULL
,	NULL
T.	NULL
1992	NULL
.	NULL

IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
127	NULL
:	NULL
25-50	NULL
.	NULL

ARUFFO	NULL
,	NULL
A.	NULL
and	NULL
SEED	NULL
,	NULL
B	NULL
.	NULL

1987	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
CD28	NULL
cDNA	NULL
by	NULL
a	NULL
high-efficiency	NULL
COS	NULL
cell	NULL
expression	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
:	NULL
8573-8577	NULL
.	NULL

BernTtzEn	NULL
,	NULL
H.B	NULL
.	NULL

and	NULL
FacerHnor	NULL
,	NULL
M.K	NULL
.	NULL

1990	NULL
.	NULL

L1	NULL
,	NULL
a	NULL
major	NULL
granulocyte	NULL
protein	NULL
;	NULL
isolation	NULL
of	NULL
high	NULL
quantities	NULL
of	NULL
its	NULL
subunits	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
50	NULL
:	NULL
769-774	NULL
.	NULL

BricoEen	NULL
,	NULL
J.	NULL
,	NULL
Tarcsay	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
,	NULL
OpmNK	NULL
,	NULL
K.	NULL
,	NULL
C/EBPa	NULL
and	NULL
-	NULL
$	NULL
in	NULL
MRP14	NULL
Gene	NULL
Expression	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

RunseaUseR®	NULL
,	NULL
M.	NULL
,	NULL
Hott	NULL
&	NULL
xpEr	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Sorc	NULL
,	NULL
C.	NULL
1988	NULL
.	NULL

The	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
cystic	NULL
fibrosis	NULL
antigen	NULL
.	NULL

Nature	NULL
,	NULL
331	NULL
:	NULL
570-573	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
UMEK	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
and	NULL
McKxiget	NULL
,	NULL
S.L	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
:	NULL
1538-1552	NULL
.	NULL

CrBaIrie	NULL
,	NULL
M.	NULL
,	NULL
Tu	NULL
,	NULL
Y.	NULL
,	NULL
EUSKIRCHEN	NULL
,	NULL
G.	NULL
,	NULL
WARD	NULL
,	NULL
W.W.	NULL
,	NULL
and	NULL
PrasHER	NULL
,	NULL
D.C.	NULL
1994	NULL
.	NULL

Green	NULL
fluorescent	NULL
protein	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
,	NULL
263	NULL
:	NULL
802-805	NULL
.	NULL

CHEN	NULL
,	NULL
P.-L.	NULL
,	NULL
RuEy	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
CHEN	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Lze	NULL
,	NULL
W.-H.	NULL
1996	NULL
.	NULL

Retinoblastoma	NULL
protein	NULL
positively	NULL
regulates	NULL
terminal	NULL
adipocyte	NULL
differentiation	NULL
through	NULL
direct	NULL
interaction	NULL
with	NULL
C/EBPs	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
:	NULL
2794-2804	NULL
.	NULL

CrHiv	NULL
,	NULL
W.	NULL
,	NULL
Niwa	NULL
,	NULL
Y.	NULL
,	NULL
ZEnc	NULL
,	NULL
W.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
SHEEN	NULL
,	NULL
J	NULL
.	NULL

1996	NULL
.	NULL

Engineered	NULL
GFP	NULL
as	NULL
a	NULL
vital	NULL
reporter	NULL
in	NULL
plants	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
325-330	NULL
.	NULL

CHumarov	NULL
,	NULL
A.M.	NULL
,	NULL
Gruier	NULL
,	NULL
I.	NULL
,	NULL
CHumax®ova	NULL
,	NULL
E.	NULL
,	NULL
Cen	NULL
,	NULL
D.	NULL
,	NULL
StaTER	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
KogrriER	NULL
,	NULL
HP	NULL
.	NULL

1997	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
novel	NULL
human	NULL
myeloid-cell-specific	NULL
C/EBP	NULL
-s	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
1375-1386	NULL
.	NULL

DeLABIE	NULL
,	NULL
J.	NULL
,	NULL
De	NULL
Worr-PEETERS	NULL
,	NULL
C.	NULL
,	NULL
VAN	NULL
DEN	NULL
OoRD	NULL
,	NULL
J.J.	NULL
,	NULL
and	NULL
DesmET	NULL
,	NULL
V.J	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
the	NULL
calcium-binding	NULL
proteins	NULL
MRP8	NULL
and	NULL
MRP14	NULL
in	NULL
granulomatous	NULL
conditions	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
81	NULL
:	NULL
123-126	NULL
.	NULL

Dorm	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Novak	NULL
,	NULL
M.	NULL
,	NULL
Hit	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Brock	NULL
,	NULL
D.J.H	NULL
.	NULL

,	NULL
SECHER	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
and	NULL
van	NULL
HEeyningEN	NULL
,	NULL
V.	NULL
1987	NULL
.	NULL

A	NULL
clue	NULL
to	NULL
the	NULL
basic	NULL
defect	NULL
in	NULL
cystic	NULL
fibrosis	NULL
from	NULL
cloning	NULL
the	NULL
CF-antigen	NULL
gene	NULL
.	NULL

Nature	NULL
,	NULL
326	NULL
:	NULL
614-617	NULL
.	NULL

GuBERT	NULL
,	NULL
JA	NULL
.	NULL

,	NULL
Ampquist	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
MaxonEy	NULL
,	NULL
D.W.	NULL
,	NULL
ZINSMEISTER	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Rusin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
EunEEsSOoN	NULL
,	NULL
R.D	NULL
.	NULL

1996	NULL
.	NULL

Fecal	NULL
marker	NULL
variability	NULL
in	NULL
colorectal	NULL
cancer	NULL
:	NULL
calprotectin	NULL
versus	NULL
he-moglobin	NULL
.	NULL

Scand	NULL
.	NULL

J	NULL
.	NULL

Gastroenterol	NULL
.	NULL

,	NULL
31	NULL
:	NULL
1001-1005	NULL
.	NULL

Goipen	NULL
,	NULL
B.E	NULL
.	NULL

,	NULL
Croxsssy	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Russe	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
FaAgERHOL	NULL
,	NULL
MK	NULL
.	NULL

1996	NULL
.	NULL

Calprotectin	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
inflammation	NULL
in	NULL
cystic	NULL
fibrosis	NULL
.	NULL

Archives	NULL
of	NULL
Disease	NULL
in	NULL
Childhood	NULL
,	NULL
74	NULL
:	NULL
136-139	NULL
.	NULL

GrunstEm	NULL
,	NULL
M.	NULL
1992	NULL
.	NULL

Histones	NULL
as	NULL
regulators	NULL
of	NULL
genes	NULL
.	NULL

Scientific	NULL
American	NULL
October	NULL
,	NULL
40-47	NULL
.	NULL

Hass	NULL
,	NULL
J.	NULL
,	NULL
PARK	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
SEED	NULL
,	NULL
B	NULL
.	NULL

1996	NULL
.	NULL

Codon	NULL
usage	NULL
limitation	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
HIV-1	NULL
envelope	NULL
glycoprotein	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
315-324	NULL
.	NULL

Hogg	NULL
,	NULL
N.	NULL
,	NULL
AureN	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
EporwortH	NULL
,	NULL
J	NULL
.	NULL

1989	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
5.5	NULL
reacts	NULL
with	NULL
p8	NULL
,	NULL
14	NULL
,	NULL
a	NULL
myeloid	NULL
molecule	NULL
associated	NULL
with	NULL
some	NULL
vascular	NULL
endothelium	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
19	NULL
;	NULL
1053-1061	NULL
.	NULL

Horie	NULL
,	NULL
N.	NULL
,	NULL
CHimoto	NULL
,	NULL
M.	NULL
,	NULL
Nozawa	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
TaxeisH1	NULL
,	NULL
K.	NULL
1993	NULL
.	NULL

Characterization	NULL
of	NULL
regulatory	NULL
sequences	NULL
and	NULL
nuclear	NULL
factors	NULL
that	NULL
function	NULL
in	NULL
cooperation	NULL
with	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
thymidylate	NULL
synthase	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1216	NULL
:	NULL
409-416	NULL
.	NULL

Hst	NULL
,	NULL
W.	NULL
,	NULL
Kerprota	NULL
,	NULL
TK	NULL
.	NULL

,	NULL
CHEN	NULL
,	NULL
P.-L.	NULL
,	NULL
CurRAN	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
CHEN-Kiancg	NULL
,	NULL
S.	NULL
1994	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
repress	NULL
transcription	NULL
activation	NULL
by	NULL
NF-IL6	NULL
through	NULL
association	NULL
at	NULL
the	NULL
basic	NULL
zipper	NULL
re-gion	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
268-276	NULL
.	NULL

Ivanov	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
MisuNo	NULL
,	NULL
N.L	NULL
,	NULL
and	NULL
Ivanov	NULL
,	NULL
V.E	NULL
.	NULL

1996	NULL
.	NULL

En-zyme-linked	NULL
immunosorbent	NULL
assay	NULL
for	NULL
human	NULL
MRP-8/MRP-14	NULL
proteins	NULL
and	NULL
their	NULL
quantitation	NULL
in	NULL
plasma	NULL
of	NULL
hematological	NULL
pa-tients	NULL
.	NULL

Immunol	NULL
.	NULL

Lett	NULL
.	NULL

,	NULL
49	NULL
:	NULL
7-13	NULL
.	NULL

JAIN	NULL
,	NULL
V.K	NULL
.	NULL

and	NULL
MagRatHg	NULL
,	NULL
LT.	NULL
1991	NULL
.	NULL

A	NULL
chemiluminescent	NULL
assay	NULL
for	NULL
quantitation	NULL
of	NULL
$	NULL
-galactosidase	NULL
in	NULL
the	NULL
femtogram	NULL
range	NULL
:	NULL
Application	NULL
to	NULL
quantitation	NULL
of	NULL
A-galactosidase	NULL
in	NULL
lacZ-trans-fected	NULL
cells	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
199	NULL
;	NULL
119-124	NULL
.	NULL

Key	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
JonEs	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
and	NULL
FrEming	NULL
,	NULL
S.	NULL
1989	NULL
.	NULL

Calgranulin	NULL
expression	NULL
in	NULL
inflammatory	NULL
dermatoses	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
159	NULL
;	NULL
17-21	NULL
.	NULL

117	NULL
23	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

KurUTO	NULL
,	NULL
R.	NULL
,	NULL
Nozawa	NULL
,	NULL
R.	NULL
,	NULL
TaxemsH1	NULL
,	NULL
K.	NULL
,	NULL
ArAL	NULL
,	NULL
K.	NULL
,	NULL
Yorota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
TAKASAKT	NULL
,	NULL
Y	NULL
.	NULL

1990	NULL
.	NULL

Myeloid	NULL
calcium	NULL
binding	NULL
proteins	NULL
:	NULL
Expression	NULL
in	NULL
the	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
and	NULL
detection	NULL
in	NULL
sera	NULL
of	NULL
patients	NULL
with	NULL
connective	NULL
tissue	NULL
diseases	NULL
.	NULL

J	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
108	NULL
:	NULL
650-653	NULL
.	NULL

Kuwarama	NULL
,	NULL
A.	NULL
,	NULL
KUurUTO	NULL
,	NULL
R.	NULL
,	NULL
HoRIE	NULL
,	NULL
N.	NULL
,	NULL
TAKEISHI	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nozawa	NULL
,	NULL
R.	NULL
1993	NULL
.	NULL

Appearance	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
genes	NULL
for	NULL
myeloid	NULL
calcium	NULL
binding	NULL
proteins	NULL
(	NULL
MRP8	NULL
and	NULL
MRP	NULL
14	NULL
)	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
81	NULL
:	NULL
3116-3121	NULL
.	NULL

LagassE	NULL
,	NULL
E.	NULL
and	NULL
CiERC	NULL
,	NULL
R.G	NULL
.	NULL

1988	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
two	NULL
human	NULL
genes	NULL
encoding	NULL
calcium-binding	NULL
proteins	NULL
that	NULL
are	NULL
regulated	NULL
during	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
2402-2410	NULL
.	NULL

LanpscHuiz	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
P.F	NULL
.	NULL

,	NULL
ApasHI	NULL
,	NULL
E.Y	NULL
.	NULL

,	NULL
Graves	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
and	NULL
McKnigHt	NULL
,	NULL
S.L	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
recombinant	NULL
copy	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
C/EBP	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
2	NULL
:	NULL
786-800	NULL
.	NULL

LECLAIR	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
BL	NULL
&	NULL
ANAR	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
and	NULL
Smarr	NULL
,	NULL
P.A	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-£B	NULL
associates	NULL
with	NULL
the	NULL
NF-IL-6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
:	NULL
8145-8149	NULL
.	NULL

McKxicHtT	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Lang	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
and	NULL
Grurcksonn-Wariscn	NULL
,	NULL
S.	NULL
1989	NULL
.	NULL

Is	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
a	NULL
central	NULL
regulator	NULL
of	NULL
energy	NULL
metabolism	NULL
?	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
:	NULL
2021-2024	NULL
.	NULL

MircHerL	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
R.	NULL
1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
pro-teins	NULL
.	NULL

Science	NULL
,	NULL
245	NULL
:	NULL
371-378	NULL
.	NULL

T.	NULL
,	NULL
KimwosHira	NULL
,	NULL
S.	NULL
,	NULL
Sasagawa	NULL
,	NULL
T.	NULL
,	NULL
SASAKI	NULL
,	NULL
K.	NULL
,	NULL
Naruto	NULL
,	NULL
M.	NULL
,	NULL
Kisamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Axia	NULL
,	NULL
S.	NULL
1993	NULL
.	NULL

Phosphorylation	NULL
at	NULL
threonine-235	NULL
by	NULL
a	NULL
ras-dependent	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
factor	NULL
NF-IL6	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
2207-2211	NULL
.	NULL

NaTsurKaA	NULL
,	NULL
S.	NULL
,	NULL
AkA	NULL
,	NULL
S.	NULL
,	NULL
NsH1o	NULL
,	NULL
Y.	NULL
,	NULL
HasHmoto	NULL
,	NULL
S.	NULL
,	NULL
Sucita	NULL
,	NULL
T.	NULL
,	NULL
Isseix1	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kiseimoto	NULL
,	NULL
T.	NULL
1992	NULL
.	NULL

Macrophage	NULL
differen-tiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
,	NULL
79	NULL
:	NULL
460-466	NULL
.	NULL

C.	NULL
and	NULL
ZIrF	NULL
,	NULL
E.B	NULL
.	NULL

1995	NULL
.	NULL

CCAAT/enhancer	NULL
binding	NULL
protein-	NULL
«	NULL
amino	NULL
acid	NULL
motifs	NULL
with	NULL
dual	NULL
TBP	NULL
and	NULL
TFIIB	NULL
binding	NULL
ability	NULL
co-operate	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
mammalian	NULL
cell	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
:	NULL
4318-4328	NULL
.	NULL

NisEtO	NULL
,	NULL
Y.	NULL
,	NULL
IssEnk1	NULL
,	NULL
H.	NULL
,	NULL
Kiseimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
AKIRA	NULL
,	NULL
S.	NULL
1993	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
interleukin-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
rat	NULL
al-acid	NULL
glycoprotein	NULL
gene	NULL
via	NULL
direct	NULL
protein-protein	NULL
in-teraction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
1854-1862	NULL
.	NULL

Nozawa	NULL
,	NULL
R.	NULL
,	NULL
Kato	NULL
,	NULL
H.	NULL
,	NULL
Ito	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Yorota	NULL
,	NULL
T.	NULL
1988	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
differentiation	NULL
antigen	NULL
human	NULL
neutrophils	NULL
and	NULL
monocytes	NULL
.	NULL

Blood	NULL
,	NULL
71	NULL
:	NULL
1288-1294	NULL
.	NULL

Opmx	NULL
,	NULL
K.	NULL
,	NULL
CERIETTI	NULL
,	NULL
N.	NULL
,	NULL
BrtooENn	NULL
,	NULL
J.	NULL
,	NULL
CriERCc	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Tarcsay	NULL
,	NULL
L.	NULL
,	NULL
Zwapio	NULL
,	NULL
G.	NULL
,	NULL
GERHARDS	NULL
,	NULL
G.	NULL
,	NULL
SCHLEGEL	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Sora	NULL
,	NULL
C.	NULL
1987	NULL
.	NULL

Two	NULL
calcium-binding	NULL
proteins	NULL
infiltrate	NULL
macrophages	NULL
of	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Nature	NULL
,	NULL
330	NULL
:	NULL
80-82	NULL
.	NULL

Osapa	NULL
,	NULL
S.	NULL
,	NULL
Takano	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
,	NULL
SUZUKI	NULL
,	NULL
T.	NULL
,	NULL
MuramaTsU	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Imagawa	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

CCAAT/enhane-er-binding	NULL
proteins	NULL
a	NULL
and	NULL
$	NULL
interact	NULL
with	NULL
the	NULL
silencer	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
glutathione	NULL
S-transferase	NULL
P	NULL
gene	NULL
during	NULL
hepato-carcinogenesis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
;	NULL
31288-31293	NULL
.	NULL

Osapa	NULL
,	NULL
S.	NULL
,	NULL
Yamamoto	NULL
,	NULL
H.	NULL
,	NULL
NisetHara	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Imagawa	NULL
,	NULL
M.	NULL
1996	NULL
.	NULL

DNA	NULL
binding	NULL
specificity	NULL
of	NULL
the	NULL
CCAAT	NULL
ing	NULL
protein	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
:	NULL
3891-3896	NULL
.	NULL

Pari	NULL
,	NULL
HL	NULL
.	NULL

,	NULL
Burn	NULL
,	NULL
T.C	NULL
.	NULL

,	NULL
and	NULL
Tenex	NULL
,	NULL
D.G	NULL
.	NULL

1991	NULL
.	NULL

Optimization	NULL
of	NULL
transient	NULL
transfection	NULL
into	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
19	NULL
;	NULL
1038-1041	NULL
.	NULL

PopE	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
LEUTZz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ness	NULL
,	NULL
S.A.	NULL
1994	NULL
.	NULL

C/EBP	NULL
beta	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55.	NULL
regulation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
94	NULL
:	NULL
1449-1455	NULL
.	NULL

POSTLER	NULL
,	NULL
E.	NULL
,	NULL
LEHR	NULL
,	NULL
A.	NULL
,	NULL
SCHLUESENER	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
MEYERMANN	NULL
,	NULL
R.	NULL
1997	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
S-100	NULL
proteins	NULL
MRP-8	NULL
and	NULL
-14	NULL
in	NULL
is-chemic	NULL
brain	NULL
lesions	NULL
.	NULL

Glia	NULL
,	NULL
19	NULL
:	NULL
27-34	NULL
.	NULL

Rox	NULL
,	NULL
D.	NULL
and	NULL
HABENER	NULL
,	NULL
J.F	NULL
.	NULL

1992	NULL
.	NULL

CHOP	NULL
,	NULL
a	NULL
novel	NULL
develop-mentally	NULL
regulated	NULL
nuclear	NULL
protein	NULL
that	NULL
dimerizes	NULL
with	NULL
transcription	NULL
factors	NULL
C/EBP	NULL
and	NULL
LAP	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
dominant-neg-ative	NULL
inhibitor	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
439-453	NULL
.	NULL

RosEtH	NULL
,	NULL
A.G.	NULL
,	NULL
Kristnsson	NULL
,	NULL
J.	NULL
,	NULL
Fagernor	NULL
,	NULL
MK	NULL
.	NULL

,	NULL
ScHronsey	NULL
,	NULL
H.	NULL
,	NULL
AADLAND	NULL
,	NULL
E.	NULL
,	NULL
NYGAARD	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
RoaLp	NULL
,	NULL
B	NULL
.	NULL

1993	NULL
.	NULL

Faecal	NULL
calprotectin	NULL
:	NULL
A	NULL
novel	NULL
test	NULL
for	NULL
the	NULL
diagnosis	NULL
of	NULL
colorectal	NULL
can-cer	NULL
?	NULL

.	NULL

Scand	NULL
.	NULL

J	NULL
.	NULL

Gastroenterol	NULL
.	NULL

,	NULL
28	NULL
:	NULL
1073-1076	NULL
.	NULL

RotH	NULL
,	NULL
J.	NULL
,	NULL
SUNDERKOTTER	NULL
,	NULL
C.	NULL
,	NULL
GorsEieR®	NULL
,	NULL
M.	NULL
,	NULL
GUrwaALD	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sora	NULL
,	NULL
C.	NULL
1992	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
calcium-binding	NULL
proteins	NULL
MRP8	NULL
and	NULL
MRP14	NULL
by	NULL
early	NULL
infiltrating	NULL
cells	NULL
in	NULL
experimental	NULL
contact	NULL
dermatitis	NULL
.	NULL

Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

,	NULL
98	NULL
:	NULL
140-145	NULL
.	NULL

Rotx	NULL
,	NULL
J.	NULL
,	NULL
GorseELER	NULL
,	NULL
M.	NULL
,	NULL
WrROCKLAGE	NULL
,	NULL
V.	NULL
,	NULL
van	NULL
pEN	NULL
Bos	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Sorg	NULL
,	NULL
C.	NULL
1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
calcium-binding	NULL
proteins	NULL
and	NULL
MRP14	NULL
in	NULL
monocytes	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
calci-um-induced	NULL
suppressor	NULL
mechanism	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
301	NULL
:	NULL
655-660	NULL
.	NULL

SAMBROOK	NULL
,	NULL
J.	NULL
,	NULL
FriItscH	NULL
,	NULL
E.F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
.	NULL

A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
6.26-6.27	NULL
.	NULL

ScHAFrER	NULL
,	NULL
B.W	NULL
.	NULL

,	NULL
WICKI	NULL
,	NULL
R.	NULL
,	NULL
EncoELKamP	NULL
,	NULL
D.	NULL
,	NULL
Matte	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
and	NULL
HEizmanx	NULL
,	NULL
C.W	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
YAC	NULL
clone	NULL
covering	NULL
a	NULL
cluster	NULL
of	NULL
nine	NULL
$	NULL
100	NULL
genes	NULL
on	NULL
human	NULL
chromosome	NULL
1q21	NULL
:	NULL
rationale	NULL
for	NULL
a	NULL
new	NULL
nomenclature	NULL
of	NULL
the	NULL
$	NULL
100	NULL
calcium-binding	NULL
protein	NULL
family	NULL
.	NULL

Genomics	NULL
,	NULL
25	NULL
:	NULL
638-643	NULL
.	NULL

ScHrEIEER	NULL
,	NULL
E.	NULL
,	NULL
Mattias	NULL
,	NULL
P.	NULL
,	NULL
MULLER	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
and	NULL
SCHAFENER	NULL
,	NULL
W.	NULL
1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
miniextracts	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
;	NULL
6419	NULL
.	NULL

Scott	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
CiviN	NULL
,	NULL
C.1I	NULL
.	NULL

,	NULL
RoxrtH	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
FRIEDMaN	NULL
,	NULL
A.D.	NULL
1992	NULL
.	NULL

A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
80	NULL
:	NULL
1725-1735	NULL
.	NULL

SELLMAYER	NULL
,	NULL
A.	NULL
,	NULL
KraNE	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
OurELLETTE	NULL
,	NULL
AJ	NULL
.	NULL

,	NULL
and	NULL
BonvENTRE	NULL
,	NULL
J.V	NULL
.	NULL

1992	NULL
.	NULL

1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
vitamin	NULL
D	NULL
;	NULL
enhances	NULL
expression	NULL
of	NULL
the	NULL
genes	NULL
encoding	NULL
Ca®*-binding	NULL
proteins	NULL
MRP-8	NULL
and	NULL
MRP-14	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
262	NULL
:	NULL
C235-C242	NULL
.	NULL

SmitE	NULL
,	NULL
L.T	NULL
.	NULL

,	NULL
Honaus	NULL
,	NULL
S.	NULL
,	NULL
GONZALEZ	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
DziEnNIs	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
and	NULL
TexENn	NULL
,	NULL
D.G	NULL
.	NULL

1996	NULL
.	NULL

PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
and	NULL
C/EBPa	NULL
regulate	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
:	NULL
1234-1247	NULL
.	NULL

STEINBAKEK	NULL
,	NULL
M.	NULL
,	NULL
NaEss-ANDRESEN	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
LINGAAS	NULL
,	NULL
E.	NULL
,	NULL
DALE	NULL
,	NULL
I.	NULL
,	NULL
BRANDTZAEG	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
FacgErHoL	NULL
,	NULL
M.K	NULL
.	NULL

1990	NULL
.	NULL

Antimicrobial	NULL
actions	NULL
of	NULL
calcium	NULL
binding	NULL
leucocyte	NULL
L1	NULL
protein	NULL
,	NULL
calprotectin	NULL
.	NULL

Lancet	NULL
,	NULL
336	NULL
:	NULL
763-765	NULL
.	NULL

TANAKA	NULL
,	NULL
T.	NULL
,	NULL
Akma	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
,	NULL
UnEMoTO	NULL
,	NULL
M.	NULL
,	NULL
YoNEDA	NULL
,	NULL
Y.	NULL
,	NULL
Seirarun	NULL
,	NULL
N.	NULL
,	NULL
FunwarRa	NULL
,	NULL
H.	NULL
,	NULL
SUemaTsSU	NULL
,	NULL
S.	NULL
,	NULL
YosHIDA	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Kisemmoto	NULL
,	NULL
T.	NULL
1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cytotoxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
:	NULL
353-361	NULL
.	NULL

TENEN	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
Lickt	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
and	NULL
ZHang	NULL
,	NULL
D.-E.	NULL
1997	NULL
.	NULL

Transcription	NULL
factors	NULL
normal	NULL
myeloid	NULL
development	NULL
,	NULL
and	NULL
leukemia	NULL
.	NULL

Blood	NULL
,	NULL
90	NULL
:	NULL
489-519	NULL
.	NULL

N.B.L	NULL
.	NULL

and	NULL
Rigsy	NULL
,	NULL
P.W.J	NULL
.	NULL

1988	NULL
.	NULL

Trans-acting	NULL
protein	NULL
factors	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
.	NULL

In	NULL
Transcription	NULL
and	NULL
Splicing	NULL
(	NULL
B.H	NULL
.	NULL

Hames	NULL
and	NULL
D.M	NULL
.	NULL

Glover	NULL
,	NULL
eds	NULL
)	NULL
,	NULL
IRL	NULL
Press	NULL
,	NULL
Oxford	NULL
,	NULL
England	NULL
1-22	NULL
.	NULL

Tose	NULL
,	NULL
T.	NULL
,	NULL
Murakami	NULL
,	NULL
K.	NULL
,	NULL
TomiTA	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Nozawa	NULL
,	NULL
R.	NULL
1989	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

R.	NULL
Kuruto-Niwa	NULL
et	NULL
a/	NULL
.	NULL

Amino	NULL
acid	NULL
sequences	NULL
of	NULL
60B8	NULL
antigens	NULL
induced	NULL
in	NULL
HL-60	NULL
cells	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

The	NULL
antigens	NULL
are	NULL
identical	NULL
with	NULL
macrophage-related	NULL
protein-14	NULL
and	NULL
-8	NULL
.	NULL

Chem	NULL
.	NULL

Pharm	NULL
.	NULL

Bul	NULL
.	NULL

,	NULL
37	NULL
:	NULL
1576-1580	NULL
.	NULL

TRAUTWEIN	NULL
,	NULL
C.	NULL
,	NULL
CaELLEs	NULL
,	NULL
C.	NULL
,	NULL
vAN	NULL
pER	NULL
GeER	NULL
,	NULL
P.	NULL
,	NULL
HunTER	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
CHorkiER®	NULL
,	NULL
M.	NULL
1993	NULL
.	NULL

Transactivation	NULL
by	NULL
NF-IL6/LAP	NULL
is	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
activation	NULL
do-main	NULL
.	NULL

Nature	NULL
,	NULL
364	NULL
:	NULL
544-547	NULL
.	NULL

TraUuTwEIN	NULL
,	NULL
C.	NULL
,	NULL
van	NULL
DER	NULL
GEER	NULL
,	NULL
P.	NULL
,	NULL
Karn	NULL
,	NULL
M.	NULL
,	NULL
HUNTER	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
CHorkiER	NULL
,	NULL
M.	NULL
1994	NULL
.	NULL

Protein	NULL
kinase	NULL
A	NULL
and	NULL
C	NULL
site-specific	NULL
phosphorylations	NULL
of	NULL
LAP	NULL
(	NULL
NF-IL6	NULL
)	NULL
modulate	NULL
its	NULL
binding	NULL
affinity	NULL
to	NULL
DNA	NULL
recognition	NULL
elements	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
93	NULL
:	NULL
2554-2561	NULL
.	NULL

TsucHiva	NULL
,	NULL
S.	NULL
,	NULL
KomayasH1	NULL
Y.	NULL
,	NULL
Goto	NULL
,	NULL
Y.	NULL
,	NULL
OxumurRA	NULL
,	NULL
H.	NULL
,	NULL
NakaE	NULL
,	NULL
S.	NULL
,	NULL
Konno	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tapa	NULL
,	NULL
K.	NULL
1982	NULL
.	NULL

Induction	NULL
of	NULL
maturation	NULL
in	NULL
cultured	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
a	NULL
phor-bol	NULL
diester	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
42	NULL
:	NULL
1530-1536	NULL
.	NULL

TsUKADA	NULL
,	NULL
J.	NULL
,	NULL
Sarto	NULL
,	NULL
K.	NULL
,	NULL
WATERMAN	NULL
,	NULL
W.R.	NULL
,	NULL
WEBB	NULL
,	NULL
A.C.	NULL
,	NULL
and	NULL
AuroN	NULL
,	NULL
P.E	NULL
.	NULL

1994	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
CREB	NULL
recognize	NULL
a	NULL
common	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
human	NULL
prointerleukin	NULL
1	NULL
}	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
7285-7297	NULL
.	NULL

Wapa	NULL
,	NULL
N.	NULL
,	NULL
Matsumura	NULL
,	NULL
M.	NULL
,	NULL
OBA	NULL
,	NULL
Y.	NULL
,	NULL
KomayasHI	NULL
,	NULL
N.	NULL
,	NULL
Takizawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Naxaxniser	NULL
,	NULL
Y	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
stimulation	NULL
of	NULL
the	NULL
Fas-encoding	NULL
gene	NULL
by	NULL
nuclear	NULL
factor	NULL
for	NULL
interleukin-6	NULL
expression	NULL
upon	NULL
influenza	NULL
virus	NULL
infection	NULL
.	NULL

J.	NULL
Bio/	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
:	NULL
18007-18012	NULL
.	NULL

Wangs	NULL
,	NULL
N.D.	NULL
,	NULL
FinEcotp	NULL
,	NULL
M.J.	NULL
,	NULL
BrapLEY	NULL
,	NULL
A.	NULL
,	NULL
Ov	NULL
,	NULL
C.N	NULL
.	NULL

,	NULL
ABDELSAYED	NULL
,	NULL
S.V	NULL
.	NULL

,	NULL
Wipe	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
TayiO®R	NULL
,	NULL
LR	NULL
.	NULL

,	NULL
Wirson	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
and	NULL
DarimGton	NULL
,	NULL
G.J	NULL
.	NULL

1995	NULL
.	NULL

Impaired	NULL
energy	NULL
homeo-stasis	NULL
in	NULL
C/EBPa	NULL
knockout	NULL
mice	NULL
.	NULL

Science	NULL
,	NULL
269	NULL
:	NULL
1108-1112	NULL
.	NULL

WEGNER	NULL
,	NULL
M.	NULL
,	NULL
Cao	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
RosEnEELD	NULL
,	NULL
M.G	NULL
.	NULL

1992	NULL
.	NULL

Calcium-regulated	NULL
phosphorylation	NULL
within	NULL
the	NULL
leucine	NULL
zipper	NULL
of	NULL
C/EBP	NULL
.	NULL

Science	NULL
,	NULL
256	NULL
:	NULL
370-373	NULL
.	NULL

Wukimson	NULL
,	NULL
MM	NULL
.	NULL

,	NULL
Busuttu	NULL
,	NULL
A.	NULL
,	NULL
Haywarp	NULL
,	NULL
C.	NULL
,	NULL
Brock	NULL
,	NULL
D.J.H	NULL
.	NULL

,	NULL
Dorin	NULL
,	NULL
J.R.	NULL
,	NULL
and	NULL
van	NULL
HEyNIngEN	NULL
,	NULL
V.	NULL
1988	NULL
.	NULL

Expression	NULL
pattern	NULL
of	NULL
two	NULL
related	NULL
cystic	NULL
fibrosis-associated	NULL
tissues	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

,	NULL
91	NULL
:	NULL
221-230	NULL
.	NULL

Wirtams	NULL
,	NULL
S.C.	NULL
,	NULL
CanTwELL	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
and	NULL
Jonson	NULL
,	NULL
P.F	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/EBP	NULL
-related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalent-ly	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
:	NULL
1553-1567	NULL
.	NULL

Youns	NULL
,	NULL
D.C.	NULL
,	NULL
KinastEy	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
RYAN	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
and	NULL
DUTEKO	NULL
,	NULL
F.J.	NULL
1993	NULL
.	NULL

Selective	NULL
inactivation	NULL
of	NULL
eukaryotic	NULL
S-galactosidase	NULL
in	NULL
assays	NULL
for	NULL
inhibitors	NULL
of	NULL
HIV-1	NULL
TAT	NULL
using	NULL
bacterial	NULL
-galactosidase	NULL
as	NULL
a	NULL
reporter	NULL
enzymes	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
215	NULL
:	NULL
24-30	NULL
.	NULL

Yu	NULL
,	NULL
S.	NULL
,	NULL
Miram	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
YamazaxK1	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
cytotoxic	NULL
factor	NULL
in	NULL
rat	NULL
peritoneal	NULL
exudate	NULL
cells	NULL
:	NULL
its	NULL
identification	NULL
as	NULL
the	NULL
calcium	NULL
binding	NULL
protein	NULL
complex	NULL
,	NULL
calprotectin	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
58	NULL
:	NULL
307-316	NULL
.	NULL

Znanc	NULL
,	NULL
D.-E.	NULL
,	NULL
HetHERINGTON	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
MeyERS	NULL
,	NULL
S.	NULL
,	NULL
RHoADES	NULL
,	NULL
K.L	NULL
.	NULL

,	NULL
Larson	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Caen	NULL
,	NULL
H.-M.	NULL
,	NULL
HieBEeRT	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
and	NULL
TENEN	NULL
,	NULL
D.G	NULL
.	NULL

1996	NULL
.	NULL

CCAAT	NULL
enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
and	NULL
AML1	NULL
(	NULL
CBFa2	NULL
)	NULL
synergistically	NULL
activate	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
:	NULL
1232-1240	NULL
.	NULL

G.	NULL
,	NULL
J.	NULL
,	NULL
GErHARDS	NULL
,	NULL
G.	NULL
,	NULL
SCHLEGEL	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Sora	NULL
,	NULL
C.	NULL
1988	NULL
.	NULL

Two	NULL
calcium-binding	NULL
proteins	NULL
associated	NULL
with	NULL
specific	NULL
stages	NULL
of	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
are	NULL
expressed	NULL
by	NULL
subsets	NULL
of	NULL
macrophages	NULL
in	NULL
inflammatory	NULL
tissues	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
T2	NULL
;	NULL
510-515	NULL
.	NULL

(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
14	NULL
,	NULL
1998	NULL
118	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
April	NULL
2	NULL
,	NULL
1998	NULL
)	NULL

